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ABSTRACT
THE EFFECTIVENESS OF RATING SCALES AND A SEMI­
STRUCTURED INTERVIEW IN DIAGNOSING ADULT 
ATTENTION DEFICIT HYPERACTIVITY DISORDER
by
Carolyn Mae Cofrancesco
Chair: Elsie Jackson
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INTERVIEW IN DIAGNOSING ADULT ATTENTION DEFICIT 
HYPERACTIVITY DISORDER
Name of researcher: Carolyn Mae Cofrancesco
Name and degree of faculty chair: Elsie Jackson, Ph.D.
Date completed: October 2007
Problem and Purpose 
There are few standardized tools for diagnosing ADHD in adults. The purpose of 
this study was to compare a standardized rating scale (CAARS) used by different 
observers, with a comprehensive diagnostic interview (CAADID) with respect to their 
ability to diagnose subtypes of ADHD.
Method
Subjects for this study came from baseline data of 98 patients (18 to 60 years of 
age) participating in a drug trial for adult ADHD. The CAADID interview results in a 
yes-no decision as to whether the patient meets DSM-IV criteria for the subtypes of
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ADHD. A ?-test was used to compare the CAADID-diagnosed and Not-Diagnosed 
subtypes with the CAARS scores as the dependent measures.
Results
The CAADID duplicates results from the CAARS, with one exception: Combined 
Subtype reported by an observer using the CAARS did not agree with the CAADID 
diagnosis.
Conclusions
In most cases different rating perspectives reveal the same picture of the patient, 
except by an outside observer. Data reveals that a childhood history and an extensive 
interview are needed to supplement ratings by an observer.
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CHAPTER I 
OVERVIEW OF THE STUDY 
Introduction
First, imagine as an adult that you have been diagnosed with a medical illness— 
cancer, depression, arthritis, diabetes, etc. Then, imagine that you go to the doctor and 
he/she tells you that although adults get this disorder, so far it has only been extensively 
researched in children and adolescents. The doctor is going to have to use 
child/adolescent criteria to make your diagnosis and medication management decisions. 
Then as a patient, understand that every time you go to see your doctor he/she will be 
“tweaking” research in order to try to help you. The doctor has no real clinical criteria of 
what the adult symptoms are; he/she can only make an educated guess as to what type of 
medical questions to ask; and research has not established what medication will best treat 
your disorder as an adult. You leave your doctor’s office knowing that you have a 
disorder that statistically puts you in a high-risk category for losing your job, family, and 
friendships. You also have a high likelihood of abusing drugs and alcohol. The disorder 
could result in problems with mood swings, depression, poor self-esteem, etc; and you 
may never reach your full potential as an adult. This is what an estimated growing 
population of adults with Attention Deficit Hyperactivity Disorder struggle with daily 
(Hechtman & Weiss, 1986)
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These individuals have a disorder that historically has been seen only as a 
problem in children and adolescents. Only recently has adult ADHD begun to be 
aggressively researched (Epstein, Johnson, & Conners, 2001). Earlier formulations 
emphasized only hyperactive symptoms, and there was a long-standing belief that 
children who were diagnosed with ADHD outgrew it. Therefore, most research stopped 
with adolescence. This left many adults struggling with the question of why they are still 
having problems transitioning into adulthood successfully.
Background of the Problem
Though many clinicians encounter adults who appear to have ADHD, there are 
problems in making the diagnosis in adults. There are several limiting features with the 
current Diagnostic and Statistical Manual o f the American Psychiatric Association 
{DSM-IV) (American Psychiatric Association [APA], 1994) as it relates to adults with 
ADHD.
First, the presentations of adult ADHD symptoms are often dissimilar to the 
DiW-ZF hyperactivity, impulsivity, and inattention symptoms found in children. For 
example, the term “hyperactive” takes quite a different form for many adults, being more 
a kind of inner restlessness than overt hyper-motility. They are not miming around their 
workplace or home environment, but may feel strong urges to move about. When 
observed from the outside they might appear to be sitting quietly, but are in fact highly 
distracted by their need to be up and on the go.
Second, because they have passed through the age of risk for other disorders, 
adults often have symptoms that mimic ADHD, such as the poor concentration of the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
anxious or depressed adult, or the impulsivity of the antisocial personality or bipolar 
patient. Therefore, comorbid psychological disorders need to be evaluated for adults.
Third, the DSM-IV fails to include some of the core symptoms of the “executive 
function” deficits that are typical of the kind of attentional problems found in adults (e.g., 
self-organization, planning, procrastination, and time management). The DSM-IV 
wording of some symptoms (e.g., “as if driven by a motor”) is inappropriate for adults. 
Phrases such as, “leaving the seat in classroom” suggest a form of hyperactivity that is 
seen much more in early childhood. Longitudinal and cross-sectional studies show that 
these symptoms decline rapidly by adolescence, but that the “attentional” symptoms 
either remain or transform into executive function deficits as subjects approach adulthood 
(Conners & Erhardt, 1998). Finally, the validity of subtyping ADHD into hyperactive, 
inattentive, and combined subtypes is unknown for adults (Epstein et al., 2001).
Currently there are very few adult ADHD assessment scales available (Dulcan & 
Benson, 1997; Weiss, Hechtman, & Weiss, 1999). According to Weiss et al. (1999), the 
following scales are some of the available adult assessment scales used by clinicians: The 
Brown Attention-Deficit Disorder Scale for Adults; Hallowell and Ratey’s 20-item list; 
and The Wender Utah Rating Scale (Ward, Wender, & Reimherr, 1993). Although these 
scales may have some validity in the assessment of adult ADHD symptoms, according to 
their manuals they are missing extensive psychometric analysis, incorporation of DSM-IV 
criteria, and major research studies to confirm validity and reliability of the measures.
It is not surprising that in the early stages of scientific research, informal and 
relatively unstandardized tests may be useful. It is from their use that clearer 
understanding of the content, scope, and practical utility emerges. But for clinicians to
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have an evidence-based and scientific practice, tests and scales should conform to the 
scientific rules for validity, reliability, and standardization, as well as practical utility. It 
is vital that clinicians know if the measures they are using are valid for their intended 
purpose. Clinicians need to see a whole picture of the patient and the illness through 
their assessment instruments. If the tests are not able to do this, they trickle down to poor 
care, inadequate data for researchers, and inappropriate criteria for diagnosing adult 
ADHD. Test development should not be turned simply into a quick, ad hoc moneymaker 
for researchers or clinicians without credible background and experience. Accountability 
has to be a priority, so test development is taken seriously by the developers of the tests. 
Therefore, the research presented in this paper will be important to clinicians in that it 
compares the results from an established instrument for measuring symptoms, the 
Conners’ Adult ADHD Rating Scales (CAARS), against a newly developed instrument, 
the Conners’ Adult ADHD Diagnostic Interview for DSM-IV (CAADID), which is a 
more comprehensive assessment from interview, childhood history, adult history, risk 
factors, and differential diagnosis.
Statement of the Problem
Currently there are several limiting factors impacting clinicians who work with 
adult ADHD patients. Most available diagnostic tools are more appropriate for children; 
there are few assessment scales available for adult ADHD. Adult symptoms are not 
always characterized correctly. Adults also have a higher risk of having other disorders 
that can mimic ADHD; and finally the DSM-IV has limited criteria regarding adult 
patient’s symptoms.
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Purpose of the Study
The purpose of this study was to compare the results from two adult ADHD tools: 
a normed rating scale for assessing ADHD symptoms, and a diagnostic interview 
covering all of the formal criteria for the diagnosis of ADHD. I wish to determine to 
what extent the rating scales completed by the patient, a doctor, and an observer are able 
to duplicate the diagnostic results from an interview by a skilled clinician, using a 
detailed history as well as all of the formal criteria required of ADHD.
Research Questions
1. Is there a difference in the mean score on the CAARS as rated by the patient 
between those patients who have been diagnosed, according to the CAADID, as 
Hyperactive/Impulsive subtype of ADHD compared to those who have not?
2. Is there a difference in the mean score on the CAARS as rated by the between 
doctor those patients who have been diagnosed, according to the CAADID, as 
Hyperactive/Impulsive subtype of ADHD compared to those who have not?
3. Is there a difference in the mean score on the CAARS as rated by the observer 
between those patients who have been diagnosed, according to the CAADID, as 
Hyperactive/Impulsive subtype of ADHD compared to those who have not?
4. Is there a difference in the mean score on the CAARS as rated by the patient 
between those patients who have been diagnosed, according to the CAADID, as 
Combined subtype of ADHD compared to those who have not?
5. Is there a difference in the mean score on the CAARS as rated by the doctor 
between those patients who have been diagnosed, according to the CAADID, as 
Combined subtype of ADHD compared to those who have not?
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6. Is there a difference in the mean score on the CAARS as rated by the observer 
between those patients who have been diagnosed, according to the CAADID, as 
Combined subtype of ADHD compared to those who have not?
Significance of the Study
This study showed the consistency of diagnosis from a new comprehensive 
interview with ratings by a: self-report (patient), doctor, and significant other using 
previously validated rating scales. Due to the positive results, the new interview 
(CAADID) could provide clinicians with a scientifically validated tool for clinical 
diagnosis, research, and for further studies of psychosocial and neurobiological aspects of 
ADHD. Conversely, the interview results can point to limitations in the use of the rating 
scales, or limitations of relying on a sole source such as an interview with the patients’ 
significant other.
Second, if doctors have a scientifically validated tool for clinical diagnosis it 
means that more adult patients will be properly treated. This would have a direct impact 
on more adults contributing to society in positive endeavors through achievement in 
leadership roles, better parenting, employment success, and educational goals. Correct 
diagnosis also results in lower healthcare costs to society, lower budget costs for 
community agencies to provide adult patient care, and lower indirect cost for universities 
in having to provide assistance to misdiagnosed students.
Limitations of the Study
The study sample was taken from adults with suspected ADHD and/or varying 
degree of Anxiety and Depression, who live near the Children’s Hospital in Montreal,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
7University of Toronto, the University of British Columbia, Yale University, and Duke 
University. Therefore, the findings from this study cannot be generalized to suspected 
ADHD adults not living near major academic centers.
Since there has not been an epidemiological study of ADHD, it is not known at 
this point whether the age, gender, comorbidities, and symptom profiles o f patients in this 
study are representative of the general population of adults referred for ADHD.
Delimitations of the Study
There are several exclusionary factors for participation in this study. Therefore 
patients who met any of the following criteria were not allowed to enroll:
1. Participants in this study should not use any other medications (over-the- 
counter, herbal, prescription, or illegal) without approval from the study doctor.
2. If a participant was pregnant or thought she might be pregnant, she could not 
enter this study.
3. To be included in the study, the participant must have been between the ages 
of 18 and 60 years.
4. Participants could not be currently abusing alcohol or illegal drugs.
5. If a participant had an eating disorder (such as anorexia or bulimia), any brain 
or nerve-related diseases, was taking any other medications for psychiatric reasons, had 
thoughts of hurting oneself, did not understand the English language well enough to 
understand what needs to be done in the study, or knew he or she could not do the study 
for the next 5 months.
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Leadership and Creating Change in the Diagnosis of Adult ADHD
There are many theories of how to create change. As with any research one hopes 
that research will have some influence or bring change to the field under study.
Therefore not only is the research itself important but also the theory the researcher picks 
to implement change. Selecting a theory also demonstrates a commitment to the process 
of leadership and accountability for one’s research. Below are two very different theories 
on implementing change and, although there are many change theories, these two were 
selected because of the respected background of both theorists.
Duke University’s Executive Education program has been ranked number one the 
past 4 years (Duke Corporate Education, 2005). Duke University also has a Leadership 
Roundtable every year that is open to leaders from various backgrounds. It is through 
this program that Duke has developed a series of leadership books on various topics. The 
book Influencing and Collaborating for Results, written in 2005 (Duke Corporate 
Education, 2005) details how to develop change after an idea has been developed. The 
foundation to this theory is the importance of communication within a collaborative team 
so that a sustainable relationship will develop with the goal of not only creating change 
for a particular project but for future projects as well.
The theory is broken down into the following two headings;
1. Collaboration: This book defines Collaboration as the act of working together, 
using united labor to work jointly with others or together, especially in an intellectual 
endeavor (Duke Corporate Education, 2005).
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In order for change to take place, one must have collaboration. When trying to 
first make change happen, most forget that many projects have interactions and 
interdependencies across departments, and without the support and resource throughout 
an organization, change becomes difficult. This connectedness includes both the system 
and process and also the people associated with the change and their interests. This book 
(Duke Corporate Education, 2005) suggests the following ways to keep communication 
open so collaboration can develop. The following credibility principles should be 
followed when working in collaborative teams:
a. Keep good company: Make sure your team members are respected in 
their field, know their job, and will keep timelines.
b. Build goodwill: It takes time to develop goodwill but if you have a 
team that is respected in the community, it makes outsiders listen to you first 
when you call.
c. Engage: Joint activity increases our understanding of one another, 
builds a common identity through shared experiences, shared hardships, and 
ongoing interaction, which creates a sense of mutual obligation for future 
interaction.
d. Make the connections: Leadership within the project -  know how to 
lead the project and the people.
2. Influence: This book (Duke Corporate Education, 2005) defines Influence as 
the power o f producing an effect without apparent exertion of force of direct exercise or 
command; to affect or alter by indirect or intangible means (Duke Corporate Education, 
2005).
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Influence is not about promoting your own agenda. It is about connecting with 
people, building a common understanding, and working together to generate a desired 
outcome. Influence involves collaboration, and this means that you are taking your idea 
for change and asking others for their input and expertise. It is a back-and-forth 
relationship which involves building and nurturing the collaborative team. In order for 
Influencing to work, the following steps are involved: understanding your network 
(group), connecting with colleagues (individual), creating the invitation (relationship), 
developing a story (only 5% to 10% are persuaded by statistics -  have a story), tailoring 
the message (make sure the story is short and easy to follow), create a shared story 
(incorporate experiences and expertise from others), and keep building credibility (keep 
the credibility principles).
The second theory is from John P. Kotter’s theory about change found in his 1996 
book entitled Leading Change. Kotter is Professor Emeritus at Harvard Business School 
and has developed an eight-stage process of creating major change.
Stage I: Establish a Sense of Urgency. Decrease complacency, which often 
means taking risks. Create a crisis by allowing a financial loss, eliminate obvious 
examples of excess, set revenue income goals so high that they cannot be reached, stop 
measuring subunit performance based only on narrow functional goals, obtain more data 
about customer satisfaction, insist that people talk regularly to unsatisfied customers, use 
consultants, put more honest discussions of the firm’s problems in company newspapers, 
and bombard people with information on future opportunities.
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Stage 2: Create the Guiding Coalition. Create a team that has the following 
members; members in a position of power, people with expertise regarding the change, 
team members who have a credible reputation, and proven leaders.
Stage 3: Develop a Vision and Strategy. The vision should convey what the 
future will look like, appeals to long-term interests of employees, and is attainable, clear, 
flexible, and easy to communicate.
Stage 4: Communicate the Change Vision. Keep it simple, use a verbal picture 
(metaphors or analogy), use multiple forums to communicate, repeat the vision many 
times, people in power must lead this vision by example, address inconsistencies in the 
vision, and two-way communication.
Stage 5: Empower Broad-Based Action. Employees need to have a shared sense 
of purpose, make structures compatible with the vision, provide training to employees, 
align information and personnel systems to the vision, and confront supervisors who 
undercut needed change.
Stage 6: Generate Short-Term Wins. Provide evidence that sacrifices are worth 
it, reward change agents, fine-tune vision, clear improvement, make it difficult for cynics 
to block change, keep the bosses on-board, and build momentum.
Stage 7: Consolidate Gains and Producing More Change. Tackle additional and 
bigger change, bring in additional people, leadership from senior management, lower 
ranks in the hierarchy are brought in too, and reduction of unnecessary interdependencies.
Stage 8: Anchor New Approaches in the Culture. This step comes last; change 
sinks in only after it is clear that it will work, talk to people a lot, change may come by
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
12
changing out people, and if promotion processes are not changed to be compatible with 
the new practices, the old culture will reassert itself.
Kotter (1996) also has two side notes when using these eight-stage approaches. 
First, change is associated in multi-step process; therefore the steps cannot be changed or 
skipped. Second, the steps are not effective if they are not driven by high-quality 
leadership, not just management.
For this research the first theory on change was implemented (Duke University). 
It was chosen because it applied best to how the initial conception of this research was 
formed. Kotter’s (1996) theory appears to work best in a setting in which the change 
takes place in a permanent infrastructure (such as IBM or a bank, etc.) and was therefore 
one reason why it was not appropriate for this study. The first stage of the Duke theory, 
collaboration, has been met (which is described below). The second stage of the Duke 
theory, influence, is in progress (which is also described below).
1. Collaboration: This research was a collaborative effort with the following 
universities: Children’s Hospital in Montreal, University of Toronto, the University of 
British Columbia, Yale University, and Duke University. This research not only took 
into account the universities but also the people who would be a part of the team: Keith 
Conners, Thomas Brown, Lily Hechtman, Umesh Jain, Diane Johnson, Donald Quinlan, 
and Margaret D. Weiss. All of these researchers are well-known experts in the field of 
ADHD. Each team member is committed to making this research process be productive 
through their commitment of adopting and following standard codes of ethics in research 
protocol along with adopting their own research code as it applied to this data. In doing
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this, the team has shown how important the credibility principles in this theory of change 
are when working in collaborative teams.
One of the key factors of the Duke change theory is that the team continues to 
work together on future projects because of the collaboration efforts they put forth in 
previous research projects. Many of these researchers on this project have worked 
together in the past and have spent years developing among themselves the credibility 
principles of keeping good company, building goodwill, keeping engaged, and making 
connections. The team also continues to work together on this project and other projects 
because of the respect they have established for each other through their collaborative 
work.
2. Influence: This collaborative team is now working on the final aspect of this 
research through writing ajournai article submission. The team is still using the 
collaborative approach along with incorporating the steps already described involved in 
the process of influence. The team is also committed to presenting papers to various 
professional conferences.
Every scientific study or idea thus has the potential for being an agent of change 
in the way individual patients are eventually understood and treated. Ultimately, 
scientific study of any disorder, such as adult ADHD in this study, must exert its effects 
through individual practitioners. In this study, I have tried to give evidence that a certain 
approach to diagnosis, the use of a comprehensive interview, has validity for diagnosing 
ADHD. It is my expectation that data from the study will prompt some practitioners to 
use this approach. If data continue to confirm the value of these tools and result in a
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wider acceptance, then I may expect initial changes in the form of compliance to result in 
a period of identification with the approach.
Definitions of Terms
The terms used in this study are defined as follows:
Attention Deficit Hyperactivity Disorder (ADHD): Those diagnosed with 
ADHD will typically present with symptoms that are grouped into inattentive, 
hyperactivity/impulsivity symptoms, or a combination of both. The symptoms for adults 
are generally supposed to include similar, though modified versions, of the childhood 
symptoms. In addition to these symptomatic criteria, DSM-IV specifies that the disorder 
must have begun in early childhood (age/onset criterion); is chronic and sustained for at 
least 6 months (chronicity criterion); is present in two or more settings (pervasiveness 
criterion); has symptoms which create impairment (impairment criterion); and cannot be 
better explained by other diagnoses (differential diagnosis criterion). A patient must 
meet all five criteria in order to be diagnosed with ADHD (American Psychiatric 
Association, 1994).
Inattentive Symptoms: One of the three subtypes of ADHD. Patients typically 
make careless mistakes, are disorganized, have difficulty listening to others, following 
instructions and trouble following tasks, avoiding tasks that require prolonged attention, 
are forgetful, and can be easily distracted.
Hyperactive/Impulsive Symptoms: One of the three subtypes of ADHD. 
Hyperactivity suggests a deficit in regulating activity levels in different settings or task 
demands. Features range from excessive talking, making noise, inability to remain 
seated, fidgets or manipulates objects when seated, restless, fidgety, intrudes on others.
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tends to speak out of turn, blurts out comments inappropriately, has trouble being patient 
or playing quietly, and moves constantly as if driven by a motor (American Psychiatric 
Association, 1994).
Combined: Both Inattentive and Hyperactive/Impulsive Symptoms.
Adult: Males or females between the ages of 18 and 60 years of age.
Diagnostic and Statistical Manual o f  Mental Disorders Fourth Edition (DSM- 
IV): The official diagnostic manual of the American Psychiatric Association. It was 
originally published in order to classify mental disorders, provide symptoms of mental 
disorders, establish research and statistical summaries of mental disorders, and assist in 
the diagnosis of mental disorders. The DSM  is periodically revised to meet changes in 
the mental health field.
Standardized Test: A measurement that is typically developed by an expert 
researcher in a particular field of academic study. Individual test items are analyzed and 
revised to insure validity and reliability. Usually, the test will have been normed and 
have specific standards of administration, scoring, and interpretation.
Comorbidity: When other psychiatric disorders may be present along with 
ADHD. These need not meet formal criteria for another disorder, but can be significant 
symptoms which complicate the diagnosis and treatment of ADHD.
Attention: Usually described as a process involving arousal or alertness, 
selective or focused attention (the ability to attend to particular stimuli while ignoring 
competing stimuli).
Attentional Capacity: The amoimt of information one can attend to at one time. 
Like IQ scores, one either has the ability to focus on numerous things at one time with
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good control (like an air traffic controller) or lacks the mental energy to focus at all 
(Sergeant, Geurts, Huijbregts, Scheres, & Oosterlaan, 2003).
Sustained Attention: Persistence of focus over time. Most humans who are 
required to focus for a long time (such as a radar watcher or airline pilot) show decline in 
their attention and loss of vigilance, which can be overcome when conditions favor high 
arousal as in a life-threatening situation (Sergeant et al., 2003).
Conners’ Adult ADHD Diagnostic Interview for D SM -IV  (CAADID): This 
interview is a diagnostic interview, based on the DSM-IV criteria, used to determine if 
adults have ADHD. It provides a comprehensive medical, social, and developmental 
history, as well as assessing the symptomatic criteria for ADHD during both adulthood 
and childhood (Epstein et al., 2001).
Conners’ Adult ADHD Rating Scales (CAARS): The CAARS used in this 
research consists of three forms: Self-Report: Long Version; Observer-Report: Long 
Version; and Observer-Report: Screening Version. These measures provide an 
assessment of the same DSM-IV adult ADHD behaviors and problems, while also 
containing factor-based scales and indexes (Conners, Erhardt, Sparrow, & MHS Staff, 
1998).
CAARS Observer-Report: Long Version and the CAARS Observer-Report, 
Screening Version: Typically in quick screening the investigator uses the CAARS 
Observer-Report: Screening Version. The CAARS Observer-Report: Long Version is 
completed by the patient’s significant other and the CAARS Observer-Report: Screening 
Version is completed by the investigator.
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Organization of the Study
This study is organized into five chapters.
Chapter 1 consists of the Introduction, Background of the Problem, Statement of 
the Problem, Purpose of the Study, Research Questions, Significance of the Study, 
Delimitations of the Study, Limitations o f the Study, Leadership and Creating Change in 
the Diagnosis of Adult ADHD, Definition of Terms, and the Organization of the Study.
Chapter 2 presents a survey of literature pertaining to the following topics: 
Overview and Prevalence of Attention Deficit Hyperactivity Disorder (ADHD); 
Impairments from ADHD; Factors That Influence an ADHD Diagnosis; History of 
ADHD Research; Manifestation of ADHD Symptoms; The DSM-IV Criteria for ADHD; 
ADHD and Comorbidity; Assessing Adults for ADHD; Current Status of Treatments for 
ADHD and a Summary.
Chapter 3 provides an Introduction; Patient Sample; Procedures; Instrumentation; 
Conners’ Adult ADHD Diagnostic Interview for DSM-IV', Conners’ Adult ADHD Rating 
Scales; Research Questions; Null Hypotheses, and Data Analysis.
Chapter 4 reviews the Purpose; Characteristics of the Sample; Findings; and the 
Summary.
Chapter 5 presents the Introduction; Problem; Purpose; Literature Review; When 
Change Occurs, Methodology; Data Analysis, Findings, Discussion of Findings; 
Conclusion, and Recommendations for Further Study.
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CHAPTER II 
REVIEW OF THE LITERATURE
Overview and Prevalence of Attention Deficit 
Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder is considered one o f the most commonly 
diagnosed psychiatric disorders of children and adolescence (Dulcan & Benson, 1997). 
The DSM-IV reports that 3% to 5% of school-aged children have Attention Deficit 
Hyperactivity and 10% to 60% of these children will have symptoms into adulthood 
(American Psychiatric Association, 1994; Milberger, Biederman, Faraone, Murphy, & 
Tsuang, 1995). It is also believed that 1% to 2% of all adults have ADHD (Shekim, 
Asamow, Hess, Zaucha, & Wheeler, 1990). Estimates of how often the disorder occurs 
(overall prevalence) depend upon how the disorder is defined. Past estimates of 
childhood ADHD have ranged between 1% and 20% of the general population. Newer 
studies using formal criteria average between 1% and 4% of the population. Very similar 
rates of childhood ADHD appear in China, Japan, Europe, India, and Latin America 
(Barkley, 1998; Conners & Jett, 2006). ADHD typically refers to a developmental 
disorder of childhood characterized by persistent patterns of inattention and/or 
hyperactivity-impulsivity. These patterns usually occur at higher frequency and severity 
than typically observed in individuals of the same age and development (American 
Psychiatric Association, 1994; Conners & Jett, 2006).
18
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The symptoms must be present before the age of 7 years and should be seen 
across two different settings (e.g., home or school/work) for at least 6 months. It is also 
not enough to say that the symptoms are present, but there also must be evidence of a 
marked interference in the person’s social, academic, or occupational functioning. These 
“impairments” should not be better explained by other disorders, such as Pervasive 
Developmental Disorders, Schizophrenia, or any other Psychotic condition (American 
Psychiatric Association, 1994).
There are three different subtypes of the symptomatic presentation in a patient. 
About 78% of boys and 63% of girls will be diagnosed with one or the other o f these 
subtypes of ADHD (Barkley, 1990). Attention Deficit Hyperactivity Disorder,
Combined Type, is the most common manifestation of ADHD in children. In this type 
the child will display both the hyperactive/impulsive symptoms and the inattentive 
symptoms. The next two subtypes are the inattentive and the hyperactive/impulsive 
subtypes. In each of these subtypes the patient will display at least six of the nine 
hyperactivity/impulsivity symptoms, or six of nine inattentive symptoms (American 
Psychiatric Association, 1994).
The DSM-IV provides an outline of behaviors typically seen in a person who has 
problems in the area(s) of inattention, hyperactivity, or impulsivity. Usually, if  a person 
has problems with attention they often do not give close attention to details, appear 
disorganized, daydreaming, and making careless mistakes. They move from task to task, 
seldom completing their work; or when they do complete the work it is often messy. The 
person often avoids work that requires sustained attention, resulting in being labeled as 
underachievers. Hyperactivity is usually expressed through the patient being fidgety
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when seated or even standing. Depending on the age and development of the person, 
they will run or climb in inappropriate situations. They will have an energy level that is 
excessive compared to most of their peers. They may fidget with objects, their body 
always seeming to be in motion (tapping hands or shaking feet). They tend to be noisier 
than their peers, and may have problems staying seated in such situations as watching 
movies or eating dinner.
Patients who are impulsive will be impatient, blurt out answers, have problems 
waiting their turn, interrupt others, be poor at following directions, and tend to grab or 
touch things excessively. Symptoms of ADHD are sometimes not observed when the 
patient is in a highly structured setting, engaged in an interesting activity, receiving one- 
on-one help, or in a setting in which rewards for appropriate behavior are given. 
Symptoms usually worsen in situations that are unstructured, boring, or require sustained 
attention or mental effort (Dulcan & Benson, 1997).
One epidemiological team (Szatmari, Offord, & Boyle, 1989) reported that it was 
more common to find children 6 to 11 years of age diagnosed with the hyperactive 
subtype. However, the hyperactive subtype seems to decline as children enter 
adolescence (Barkley, 1990). The hyperactive subtype is much more common in boys 
than girls. Boys appear to have ADHD anywhere from 10 times to 2 times more often 
than girls (Rowland, Lesesne, & Abramowitz, 2002; Scahill & Schwab-Stone, 2000). It 
appears that even though girls have a lower risk of the hyperactive subtype the girls are 
just as prone to develop conduct disorders as the boys (Manuzza et al., 1991).
Impairments From ADHD
ADHD is a chronic, lifetime disorder that takes a considerable toll on those
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suffering from it as well as the families and communities who care for these individuals. 
It is believed that 80% of children will continue to have symptoms into adolescence and 
66% will have symptoms in adulthood (Barkley, 1997). One third of adults continue to 
exhibit all of the symptoms of ADHD, in a somewhat altered form, and as many as 60% 
of adults continue to have at least one significant impairing symptom (March, Wells, & 
Conners, 1995).
Significant proportions of those with ADHD end up with serious social, 
emotional, interpersonal, and economic limitations. Ninety percent carry a high risk for 
school failure, 35% to 50% will be retained in a grade level, 36% will not graduate from 
high school, and 50% will be underachieving in their employment (Barkley, 1997). 
Those diagnosed can have greater risk of death by misadventure; driving accidents; 
teenage pregnancy; sexually transmitted diseases; alcohol and other substance abuse; 
academic underachievement; and profound impairment of self-esteem (Conners & 
Erhardt, 1998).
In a classic study, Satterfield, Swanson, Schell, and Lee (1994) found, after 
reviewing court records, that hyperactive youths (ages 14 to 21) were four to five times 
more likely to have been arrested and had 25 % higher rates of being incarcerated. 
Despite criticisms that such findings represent the comorbidity of ADHD with Conduct 
Disorder (Earll, 1995), rebuttals seem convincing (Satterfield, 1995). Satterfield et al. 
(1994) reported that in a follow-up study of 66 subjects ages 15 to 26, 30% of the 
subjects had problems with the police (as cited in Hechtman & Weiss, 1986).
Executive functioning skills are also decreased in ADHD patients. Executive 
functioning includes cognitive characteristics such as: being disorganized, being
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forgetful (e.g., making lists, then forgetting to use them), losing things, failing to plan 
ahead, depending on others for maintaining order, not being able to keep track of several 
things at once, not finishing projects or tasks, needing an absolute deadline in order to get 
things done, not being able to get started on tasks, changing plans/jobs in midstream, 
misjudging available time. Tests that measure frontal lobe functions are more likely to 
reveal these executive weaknesses in ADHD patients. Frontal lobes are the last parts of 
the brain to mature, and they are responsible for the control of attention as well as control 
over motor activity (Alexander & Stuss, 2000). Magnetic resonance imaging (MRI) has 
shown the frontal lobes of ADHD children and adults to be less mature than normal 
children (Giedd, Blumenthal, Molloy, & Castellanos, 2001). The Conners’ Scales also 
have a factor that includes all the executive functioning characteristics (Conners et al., 
1998).
Factors That Influence an ADHD Diagnosis
Currently no single cause of ADHD has been discovered. However, it is known 
that ADHD has strong genetic links. Studies on adults with ADHD have shown that 
children of ADHD parents have twofold to eightfold increases for the risk of developing 
ADHD (Biederman & Faraone, 2002). Other researchers (Manshadi, Lippmann, 
ODaniel, & Blackman, 1983) examined siblings of ADHD adults and found a higher rate 
of ADHD among the siblings, consistent with the high rates of children of parents who 
have ADHD. These family genetic links provide evidence for the validity of Adult 
ADHD. Paul Wender, one of the pioneers in recognizing adult ADHD, also carried out 
family genetic studies showing increased rates o f ADHD and ADHD characteristics in 
relatives of children who are hyperactive (Wender, 1995).
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Twin studies provide further powerful support for genetic contributions to 
ADHD. Differences between twins and siblings in behavior problems were investigated 
in a sample of 1,938 families with children ages 4-12 years. Families were sent a 
questionnaire for Attention Deficit Hyperactivity Disorder (ADHD). The questionnaire 
also included measures of speech and reading problems. There were significant 
differences between twins and siblings for ADHD symptoms, but not for symptoms of 
other disorders. There was a strong association between ADHD symptoms and speech 
and reading problems (Levy, Hay, McLaughlin, Wood, & Waldman, 1996). In another 
study 81 % of identical twins had ADHD, compared with 29% of the fraternal twins 
(Weiss et al., 1999). Faraone et al. (2000) found that 57% of adults with ADHD would 
have children who also have ADHD (Faraone et ah, 2000). Early studies by Safer in 
1973 looked at full and half siblings that had been removed from their homes. He found 
that 50% of the full siblings (versus 10% of the half siblings) were diagnosed with 
ADHD (Wender, 1995). Family patterns o f ADHD in girls appear to be very similar or 
even stronger than those of boys (Arcia & Conners, 1998; Biederman et ah, 1994; Gaub 
& Carlson, 1997).
Another study made psychiatric and intellectual assessments o f 140 children with 
ADHD, 120 normal controls, and their 303 siblings. ADHD children were more likely to 
have had learning disabilities, repeated grades, been placed in special classes, and 
received academic tutoring than their siblings or normal controls. Intellectual impairment 
was increased among siblings of ADHD children. This provides converging evidence that 
the ADHD syndrome is familial (Faraone et ah, 1993).
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Recent developments in molecular biology have led to several studies of genetic 
influences in ADHD through molecular gene isolation. These studies complement the 
multi-generational studies and clarify the specific nature o f the genetic link to this 
condition. There are two approaches being pursued. The first is a genome scan in which 
the locations of all the chromosomal patterns are found in order to find the genes that 
may be related to ADHD behaviors. Second, is the study of certain candidate genes 
theorized as linked to ADHD (Biederman & Faraone, 2002). There appears to be strong 
genetic evidence involving the D4 dopamine receptor gene (DRD4). This gene regulates 
the post-synaptic receptors for the neurotransmitter dopamine (Faraone et al., 2000). The 
gene-regulating transporter re-uptake of dopamine into the pre-synaptic neuron (DATl) 
has also been found to be defective in samples of ADHD. In this case, the abnormal gene 
creates a more efficient re-uptake of dopamine, thus lowering the availability of the 
neurotransmitter in the synaptic cleft. It is not accidental that drugs that work best with 
ADHD, such as methylphenidate, act to block re-uptake of dopamine, thus increasing the 
amount of available dopamine to the post-synaptic receptors. Figure 1 gives a good 
visual overview of this process (Conners, 2003).
Functional magnetic resonance imaging (fMRI) o f ADHD patients is currently 
being studied. These studies will give a more precise visualization of different areas of 
the brain and provide a more accurate understanding of the areas o f the brain that are 
affected by ADHD. The one drawback has been that nearly all adolescent studies have 
used structural imaging whereas adult studies use functional imaging, which makes it 
difficult to compare the results between children and adolescents (Faraone et al., 2000).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
25
Catecholamine (Dopamine, 
Norepinephrine) Dysregulatlon In ADHD
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Figure 1. Catecholamine dysregulatlon in ADHD.
One MRI study found that 57 boys with ADHD showed significant anatomic 
differences in their brain structure when compared to children who did not have ADHD 
(Weiss et ah, 1999). So far, structural neuroimaging studies involving ADHD juveniles 
have indicated alterations in the brain involving the prefrontal cortex, the striatum, 
cerebellum, and the corpus callosum (Faraone et ah, 2000). Currently, Dr. Nora D.
Voikow, of the Medical Department of Brookhaven National Laboratory, is studying the 
use of Positron Emission Tomography (PET) to determine the effects o f methylphenidate 
(MPH) in the human brain. Some of the brain imaging results from these studies show 
that it takes about 60-90 minutes for MPH to reach its peak levels in the brain and that
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MPH blocks more than 50% of the dopamine transporters (Volkow, Fowler, Wang, Ding, 
& Gatlely, 2002).
Some researchers hold strongly that there is no single cause of ADHD, and that it 
can be traced to a variety of genetic, medical, temperament, social, and environmental 
risks (March et al., 1995). It is felt that along with medical factors, psychosocial 
variables are also important as causes of ADHD. These multiple factors, sometimes in 
combination, include fetal alcohol syndrome, fetal or prenatal traumas, narcotics, 
temperament risks, and children at risk due to poverty, abuse, psychosocial trauma, or 
parental psychopathology. National samples of ADHD and related problem behaviors 
show little or no differences in racial or ethnic background (Achenbach, Howell, Quay, & 
Conners, 1991). Such studies show that social issues play a significant role in the 
development of ADHD, with no major differences accounted for by race or ethnicity 
once social class and education are taken into account (Conners, 2003). These findings 
make sense in that the brain itself is markedly shaped by the environment and not just 
neurobiological influences. In the area of education, further studies need to be done to 
understand how to increase children and adult success in school and the impact ADHD 
has on learning (Weiss et al., 1999).
A number of risk factors have been identified, particularly those affecting early 
development of the fetal brain, such as maternal alcohol and tobacco use, environmental 
toxins (lead), and lack of crucial nutrients such as iron and calcium (Nichols & Chen, 
1981). Animal studies show that pregnant mice chronically exposed to nicotine have 
hyperactive offspring (Biederman & Faraone, 2002). It has also been found that nicotine
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exposure results in dopamine disruption, which, as already stated, is one of the target 
areas considered as a cause of ADHD (Biederman & Faraone, 2002).
It has also been suggested that hyperactivity in infancy, conduct disorders, 
antisocial behavior in first-degree relatives, problems in delivery or prenatal functioning, 
developmental delays, neglect, abuse, and severe early trauma are all possible risk factors 
(Lirmet et al., 2003). These risk factors become more significant as the risk outweighs 
protective factors, which mitigate the disorder (March et al., 1995). Some of the factors 
that are considered as ADHD “protective factors” are a positive family environment, 
access to educational resources, a healthy lifestyle, and high intelligence. Figure 2 gives 
a good visual overview of this global theory of the causes of ADHD.
Note that the risk factors are common to a number of different types of childhood 
dysfunction. Thus, the problems of self-regulation typical of ADHD might also be 
complicated by cognitive, mood, or social dysfunctions.
At various times it appears that research is driven more by popular misconception 
of ADHD than by facts. For instance, it was thought that ADHD was caused by sugar 
intake, food allergies, food additives, florescent lights, or folic acid deficiency. Studies 
on the Feingold diet (elimination of food additives) and reductions of sugar intake found 
that none of these theories are empirically valid (Biederman & Faraone, 2002). Many of 
the so-called theories were simply schemes to make money with expensive treatment 
plans for patients (Weiss et al., 1999). The Feingold diet was, however, an honest theory 
put forward on the basis of clinical experience in an allergy setting. The fact that it was 
discredited by research does not impugn the integrity of Dr. Feingold, who was a sincere 
advocate of this approach.
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The Risk Model of ADHD Risk Outcomes
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Figure 2. The risk model of ADHD.
One popular theory, which did help in the understanding of ADHD, was the 
thought that a chemical imbalance was the cause of ADHD. It has been foimd through 
empirically based research that dysregulatlon of dopamine, norepinephrine, and serotonin 
may in fact play a role in ADHD (DiMaio, Grizenko, & Joober, 2003; Solanto, 2002). 
Stimulant drugs such as methylphenidate or dextro-amphetamine appear to stabilize and 
reverse this chemical imbalance by facilitating the release of catecholamines (dopamine 
and norepinephrine), and by blocking their re-uptake.
History of ADHD Research
Russell Barkley’s book (1990), Attention Deficit Hyperactivity Disorder: A 
Handbook for Diagnosis and Treatment, provides a detailed historical perspective on
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ADHD. According to Barkley’s book, ADHD symptoms in children were first written 
about in the early 1900s. These early papers by the pediatrician George Still presented 
ADHD in medical terms and described the cognitive and behavioral effect of this 
disorder as if it was an injury such as a trauma or infection. George Still and Alfred 
Tredgold are noted as being the first researchers to give serious focus to the attention and 
behavioral conditions of children who appeared to have symptoms of what we would 
consider today as ADHD (Still, 1902; Tredgold, 1908).
Still (1902) noted that these children were often more aggressive, defiant, and 
resistant to discipline. He was the first to define the symptoms of the disorder as being a 
medical concern compared with the normal behavior of children the same age, suggesting 
that an age-reference criterion was important in the diagnosis of ADHD. He also wrote 
that children who came from homes that had poor child-rearing practices should not be 
included in the category of this disorder. He proposed that there was some biological 
predisposition to the behavior. He suggested possible hereditary or prenatal or postnatal 
injury played a role. He felt improvement in the condition could come by means of a 
special education environment or medication.
In 1917-1918, North American researchers became interested in the disorder after 
an encephalitis epidemic. Clinicians were asked to treat many children who had survived 
the epidemic but appeared to be left with significant behavioral problems in the areas of 
attention, regulation of activity level, cognitive impairment, socially disruptiveness, and 
poor impulse control. The children were diagnosed with “Postencephalitic Behavior 
Disorder” as a result of central nervous system damage. It was recommended that the 
children receive alternative educational placement and/or outside home placements.
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After modifications were put into place, the researchers noted that the children showed 
significant strides in their behavior (Barkley, 1990).
As the research of the “disorder” started to take form so did finding a name for it. 
Some researchers referred to it as Organic Driveness Disorder (Kahn & Cohen, 1934), 
Minimal Brain Damage (Tredgold, 1908), or the Restlessness Syndrome (Childers,
1935). It appears that by the 1950s and 60s the term MBD, Minimal Brain Dysfunction 
(Clements, 1966), became the standard name used by clinicians to describe these 
symptoms in children. Towards the end of the 1960s the name started to change again. 
This time clinicians used more specific terms such as Dyslexia, Language Disorder, 
Learning Disabilities, and hyperactivity. But the criteria were so broad that they included 
virtually the whole range of childhood psychiatric impairments.
A paper written by Stella Chess (1940) brought the research of the disorder into 
modem times. In her paper she defined the features of the disorder, the need for 
objective evidence of the symptoms, removal of blame from the parents, and separating 
the concept of the syndrome of hyperactivity from the concept of a Brain Damage 
Syndrome. She defined the hyperactive child as “one who carries out activities at a 
higher than normal rate of speed than the average child, or who is constantly in motion, 
or both.” After her publication, the DiW -//created the category o f Hyperkinetic 
Reaction of Childhood Disorder. However, the diagnostic manual provided only a brief 
description of the disorder and gave few useful details on how to diagnose it (Barkley, 
1990).
By the 1970s the study of Hyperkinetic Reaction of Childhood Disorder was 
taking off with over 2,000 published studies, numerous clinical and scientific textbooks,
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scholarly reviews of literature, scientific gatherings, and journal issues devoted to the 
topic. The disorder started to take on more definition, and researchers started to question 
what causes this disorder, including the possibility that these children’s brains develop 
differently. Researchers such as Virginia Douglas, at McGill University, Susan Campell, 
and Gabrielle Weiss were the leaders in asking and researching these questions. It is 
believed that Virginia Douglas’s research was the major reason why the disorder was 
renamed as Attention Deficit Disorder (ADD) in 1980 by the DSM-IIl. The DSM-III 
took a different stance on what ADD is by including in the definition that sustained 
attention and impulse control were a greater significance in the diagnoses than the 
symptoms of hyperactivity. In his review of the history of medication treatment for 
ADHD, Barkley (1990) points out that Keith Conners, Leon Eisenberg, Robert Sprague, 
Virginia Douglas, and John Werry were among the early researchers examining how to 
treat the disorder with medication. With the advent of drug studies, it also became 
necessary to delineate criteria for the disorder as well as to find ways to measure changes. 
The early development of teacher and parent rating scales by Conners and others 
contributed to making the disorder among the well-studied areas in child psychiatry 
(Barkley, 1990).
Currently, methylphenidate is the most commonly used stimulant in the treatment 
o f ADHD. Over 1,500 of the current ADHD studies use methylphenidate. Charles 
Bradley (1937) was one of the first researchers to use stimulants. He originally used 
Benzedrine (a form of amphetamine), hoping it would cure headaches. Instead it was 
found that the patients had a markedly improved attention span. The stimulant was soon 
referred to as the “math pill” because students were able to sit long enough to finish their
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math work (Conners, 2002). Maurice Laufer was Bradley’s successor as medical director 
of the Bradley Home for Children. Laufer continued Bradley’s work, but added to the 
research by defining the symptoms of the disorder, including both hyperactivity and 
inattention in the criteria (Conners, 2002).
In 1957 the FDA approved Ritalin® for the treatment of hyperactivity, 
impulsivity, and inattention. However, it was not until the 1960s that the first controlled 
trials of Ritalin® were researched by Dr. Conners and Dr. Eisenberg. Several meta­
analyses of the drug studies have consistently shown that the stimulant methylphenidate 
and the amphetamines improve symptoms of ADHD in about 70% to 80% of the children 
being treated (Kavale, 1982; Ottenbacher & Cooper, 1983; Thurber & Walker, 1983).
As more research on ADHD emerged, the definition and name changed again.
The DSM-III-R changed the name to Attention Deficit Hyperactivity Disorder along with 
redefining the criteria. Some of the changes included the following: a single list of 
symptoms and a single cut-off score; the item list was now based on empirically based 
dimensions of a child’s behavior; and the need to establish the symptoms as being 
developmentally inappropriate for the child’s mental age. The 1980s and 90s brought 
improved research, neurological studies, development of assessment tools, new 
approaches to treatment, and public awareness of this disorder as a disability. One of the 
positive changes came with the 1994 release of the DSM-IV, in which some guidelines 
were also included to facilitate helping in diagnosing adults.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
33
Manifestation of ADHD Symptoms
Adults and children manifest symptoms of ADHD very differently. Therefore it 
is important for families and the patient to understand how their symptoms change over 
developmental stages. Not only are the children affected by the disorder, but the entire 
family suffers. Families who have children with ADHD have higher levels of marital 
discord, sub-optimal parenting practices, and parenting distress (Lambert, Hartsough, 
Sassone, & Sandoval, 1987). Consequently, understanding the patient can lead to a better 
understanding of the family’s dynamics and how it can be negatively impacted through 
the disorder. In Barkley’s (1990) study it was found that hyperactive children were less 
compliant, more negative, more off task, and less able to sustain compliance to their 
mom’s redirections compared to non-ADHD children. The mothers were more 
commanding and negative, and less responsive to positive or neutral communications 
from their children, compared to mothers who had children without ADHD. Studies also 
indicate that even when there are improvements in ADHD behavior, parent-child 
conflicts seem to be more of a problem within ADHD households compared to non- 
ADHD households (Barkley, 1990).
Typically, parents and schools see higher rates of ADHD symptoms in children 
between the ages of 6 and 12 (Conners & Jett, 2006). Usually the child will have a 
marked impairment in one or more of the following domains: family relationships, peer 
status, social skills, academic achievement, self-esteem/self-perception, and accidental 
injury (National Institute o f Mental Health [NIMH], 1998).
In the social domain, children with ADHD are usually not welcomed into their 
peer groups. This rejection by their peers can lead to school dropout, delinquency.
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behavior problems in school, poor motivation in school, poor self-esteem, depression, 
and attendance problems (Lambert et ah, 1987). These behaviors coupled with the 
ADHD symptoms can result in the vast majority of ADHD children and adolescents not 
working up to their educational potential. Within a school setting the teachers may see 
some of the following ADHD symptoms: easily distracted, engaged in off-task activities, 
unable to sustain attention, impulsive behaviors, displays of aggression, acts like the 
“class clown,” has increasing difficulties with peer relations, poor organizational skills, 
and does not finish tasks, etc. (Conners & Jett, 2006).
As noted previously, these symptoms in childhood have generally been broken 
down into two categories of either inattention or hyperactivity. Inattention symptoms 
include failing to give close attention to details or making careless mistakes, having 
difficulty sustaining attention, not listening, not following through, having difficulty 
organizing, avoidance or dislike of sustained mental effort, losing things, being easily 
distracted, and forgetfulness. Hyperactivity symptoms include fidgeting, being out of 
seat, running or climbing excessively, having difficulty playing quietly, being “on the go” 
or as if “driven by a motor,” talking excessively, blurting out answers, having difficulty 
awaiting turn, and often interrupting or intruding on others (Dulcan & Benson, 1997).
Adults may demonstrate symptoms in failure to achieve academically or 
occupationally, difficulty keeping jobs, an inability to sustain relationships, somatic 
complaints, violent behaviors, poor stress tolerance, and drug/alcohol abuse. Manuzza et 
al. (1991) undertook a 13- to 19-year follow-up study of 91 males who had been 
diagnosed with ADHD with a final mean age of 26 years. Eleven percent of the males in 
the study continued to have clinically impairing symptoms into adulthood. The study
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also found that the men ranked lower in social class, had lower academic achievement, 
and completed 2.5 fewer years of school. In addition, 25% of them dropped out of school 
by the 11*'^  grade. Twelve percent achieved a bachelor’s degree or higher, had an 
increased risk of incarceration, a higher incidence of mental disorders, were 10 times 
more likely to have antisocial personality disorders, and 5 times more likely to have 
substance abuse problems.
Adults with ADHD often compensate for their disorder in the following ways 
(Manuzza et al., 1991):
1. Either withdrawing or participating in high-stimulus activities
2. Obsessive-compulsive type behaviors, such as making lists or charts often 
overwhelming adults leaving them still disorganized and unproductive
3. Fail to live up to occupational potential and work in jobs they are overqualified
4. Relationships fail, are avoided all together, or become very intense where the 
adult overvalues relationships with others or becomes submissive.
The following breakdown gives a realistic view of some symptoms and struggles 
that an adult with ADHD can sometimes deal with on a day-to-day basis (Hallowell & 
Ratey, 1994b).
1. Hyperactivity-Related Symptoms
a. Inability to relax
b. Restless sleep
c. Excessively active lifestyle
d. Constant purposeless motion of extremities
e. Obsessive-compulsive, stimulus-seeking, or antisocial behaviors
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2. Impulsivity-Related Symptoms
a. Disinhibition
b. Alcohol or other drug (especially caffeine) abuse
c. Family violence
d. Speaking or making decisions without considering consequences
3. Inattention-Related Symptoms
a. Disorganization and inefficiency
b. Procrastination
c. Failure to plan ahead
d. Forgetfulness
e. Difficulty in multitasking
f. Misjudging how long it takes to perform tasks
g. Inability to complete tasks
h. Distractibility
i. Poor ability to follow long explanations
4. Other Symptoms
a. Rapid, brief mood shifts or over-excitability
b. Hot temper
c. Low self-esteem; feelings of inadequacy
d. Stress-intolerance; feeling chronically overwhelmed
e. Stubbornness
f. Driving infractions
g. Difficulty in keeping jobs or sustaining relationships
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h. Failure to live up to occupational potential 
Not all adults with ADHD have learning problems or other psychological and 
social difficulties. They can be creative, gifted, and intelligent people. At a second 
glance, many of the characteristics of ADHD could be seen as advantageous: a high 
energy level, talkativeness, an orientation to action, daring, stubbornness, hands-on, and 
curious, etc. Benjamin Franklin (among others) is considered to have had ADHD. It is 
sometimes thought that Benjamin Franklin’s ADHD-like characteristics may have been 
the reason for his success (Burd & Kerbeshian, 1988).
The Z)5 M -/F Criteria for ADHD
When clinicians make a diagnosis of a patient they usually follow the standards
set by the most current edition of the Diagnostic and Statistical Manual o f  Mental
Disorders - IV  (DSM-IV). The following is a detailed outline taken directly from the
DSM-IV o f the diagnostic criteria for Attention-Deficit/Hyperactivity Disorder:
A. Either (1) or (2)
(1) six (or more) of the following symptoms of inattention have persisted 
for at least 6 months to a degree that is maladaptive and inconsistent with 
developmental level:
Inattention
(a) often fails to give close attention to details or makes careless 
mistakes in schoolwork, work, or other activities
(b) often has difficulty sustaining attention in tasks or play 
activities
(c) often does not seem to listen when spoken to directly
(d) often does not follow through on instructions and fails to finish 
schoolwork, chores, or duties in the workplace (not due to oppositional 
behavior or failure to understand instructions)
(e) often has difficulty organizing tasks and activities
(f) often avoids, dislikes, or is reluctant to engage in tasks that 
require sustained mental effort (such as schoolwork or homework)
(g) often loses things necessary for tasks or activities (e.g., toys, 
school assignments, pencils, books, or tools)
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(h) is often easily distracted by extraneous stimuli
(i) is often forgetful in daily activities
(2) six (or more) of the following symptoms of hyperactivity-impulsivity 
have persisted for at least 6 months to a degree that is maladaptive and 
inconsistent with developmental level:
Hyperactivity
(a) often fidgets with hands or feet or squirms in seat
(b) often leaves seat in classroom or in other situations in which 
remaining seated is expected
(c) often runs about or climbs excessively in situations in which it 
is inappropriate (in adolescents or adults, may be limited to subjective 
feelings of restlessness)
(d) often has difficulty playing or engaging in leisure activities
quietly
(e) is often “on the go” or often acts as if “driven by a motor”
(f) often talks excessively 
Impulsivity
(g) often blurts out answers before questions have been completed
(h) often had difficulty awaiting turn
(i) often interrupts or intruded on others (e.g., butts into 
conversations or games)
B. Some hyperactive-impulsive or inattentive symptoms that caused impairment 
were present before age 7 years
C. Some impairment from the symptoms is present in two or more settings (e.g., 
at school or work) and at home)
D. There must be clear evidence of clinically significant impairment in social, 
academic, or occupational ftmctioning
E. The symptoms do not occur exclusively during the course of a Pervasive 
Developmental Disorder, Schizophrenia, or other psychotic Disorder and are not 
better accounted for by another mental disorder (e.g., Mood Disorder, Anxiety 
Disorder, Dissociative Disorder, or a Personality Disorder) (APA, 1994, pp. 84- 
85)
Most research on diagnosing adult ADHD indicates that there is a serious need for 
research on how best to gather patient information in order to make a diagnosis and to 
determine what instruments are most useful. Adler and Cohen (2004), Riccio et al.
(2005), and Liu and Stein (2004) emphasize reminding clinicians to use sound practices 
when diagnosing, and treating adult ADHD patients. These authors emphasize that adult 
ADHD is a clinical diagnosis and a clinician-administered interview remains the
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cornerstone of the diagnostic evaluation. Adler (2004) emphasizes in case study reports 
that the use of retrospective reporting and rating scales are not only vital in determining 
an ADHD diagnosis but these tools also assist in discovering comorbidities and family 
histories of ADHD. The importance of having a correct diagnosis in psychiatry is 
demonstrated in Faraone et al. ’s (2004) research. They reviewed over 800 medical 
records o f adults diagnosed as having ADHD. Only 25% of the adults with ADHD had 
been first diagnosed as having the disorder in childhood or adolescence. They found that 
a diagnosis of ADHD was the initial cause for referral in 80% of the psychiatric patients, 
and 60% of the patients seen by their primary care physician. Fifty-six percent of the 
patients had complained about ADHD symptoms to other health care professionals but 
were never diagnosed. Primary care physicians were the least aggressive in diagnosing 
ADHD. This article also emphasizes the importance for clinicians of knowing how to 
diagnose ADHD correctly so patients can be treated appropriately.
Current research demonstrates that there are several tools for assessing adults that 
are available but their ability to diagnose ADHD accurately is poorly understood, making 
it even more vital that clinicians know what tools they should or should not use when 
working with patients. McCann and Roy-Byme (2004) researched three ADHD scales: 
Adult Rating Scales (ARS), Attention Deficit Scales for Adults (ADSA), and the 
Symptom Inventory for ADHD. This research found that all three instruments were 
sensitive to the presence of symptoms in adults (correctly identifying patients) but they 
also had a high proportion of individuals with non-ADHD diagnoses who were screened 
positive, incorrectly identifying between 36% to 67% as ADHD. Murphy and Adler 
(2004) reviewed numerous scales and again point out the lack of research establishing the
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usefulness of self-administered rating scales compared with investigator-administered 
scales in the assessment and diagnosis of adult ADHD. One study (Oncu et al., 2004) 
examined the Achenbach (Child Behavior Checklist [CBCL]) and Teacher Report Form 
(TRF). He found that these scales under diagnose and may cause an emerging problem 
as these large numbers of misdiagnosed children get older. Rosier et al. (2004) 
completed research on a German adult self-rating questionnaire (ADHD-SR) and a 
diagnostic checklist (ADHD-DC). This research found that these two tools correlated 
well, and had a high correlation with another adult-rating scale, the Wender Utah Scale.
ADHD and Comorbidity
A variety of other disorders can be mistaken for ADHD. Impaired vision or 
hearing, seizures, early onset of Bipolar Disorder, Mental Retardation, Learning 
Disabilities, difficult temperament, head trauma, acute or chronic medical illness, poor 
nutrition, insufficient sleep. Anxiety Disorders, Depression, abuse or neglect, and 
Tourette’s Disorder can mimic symptoms of ADHD. Drugs such as phénobarbital, 
alcohol, illicit drugs, and perhaps some asthma drugs can also give the patient the 
appearance of having symptoms of ADHD (Dulcan & Benson, 1997). Comorbidity of 
ADHD with other psychiatric disorders can be as high as 77% (Weiss et al., 1999). It is 
therefore not enough for the clinician to know the criteria for the diagnosis of ADHD; the 
clinician must also be able to distinguish its symptoms from other conditions that may 
resemble ADHD. Montano (2004) found that the majority of adults with ADHD have 
not been properly diagnosed or treated because of comorbidity and lack of diagnostic 
information. Most adults exhibit at least one comorbid symptom from one of the 
following psychiatric disorders; major depressive disorder, anxiety disorder, personality
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disorder, substance abuse disorder, or bipolar disorder. Comorbidities compound the 
difficulty in making an adult diagnosis, therefore making it important to look for 
established early (childhood) symptoms and persistent (lifelong) history. Montano’s 
research emphasizes the lack of current data on rating scales and other diagnostic tools 
and how important this research is in the field of adult ADHD.
Biederman et al. (1993) studied 84 adults referred with and without ADHD and a 
group of children with ADHD. Seventy-seven percent of the adults referred for ADHD 
met the criteria for comorbidity. The difficulties included oppositional, problems with 
aggression, depression, anxiety, learning, or hypomania. They also found that there was 
no difference in patterns of comorbidity in diagnosed children and adults, suggesting that 
the pattern of presentation of adult ADHD is similar to childhood ADHD, and that a 
higher level of comorbidity is to be expected with adult patients. Symptoms of ADHD 
overlap with other disorders, such as Depression with agitation. Generalized Anxiety 
Disorder, Primitive Personality Disorders, Thought Disorders, Cyclothymia, and Organic 
Disorders. Depression and ADHD have overlapping symptoms in the DSM-IV. Of the 
nine categories listed in the DSM-IV for Depression, six of them are also associated with 
ADHD. Here again, following the developmental course of the symptoms is important. 
In ADHD, the demoralization and sadness are constant features, dating from very early 
failure experiences, as opposed to the late onset of true depressive syndromes.
Biederman et al. (1993) found that 31% of adults referred with ADHD meet the full 
diagnostic criteria for a Major Depressive Disorder. They also found that about 30% of 
adults with ADHD reported problems with depression in childhood.
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A variety of hypotheses have been developed to explain the comorbidity between 
ADHD, Mood Disorders, and Depression. Possibly, ADHD could be a variant of Mood 
Disorders or Mood Disorders could be an outcome of ADHD. It could also be that the 
two disorders are genetically linked (Faraone & Biederman, 1997). Depression could 
also be secondary to living with ADHD (Weiss et al., 1999). At present there is 
disagreement among psychiatrists about the relationship between Mania/Bipolar and 
ADHD. Some of the disagreement reflects the vagueness of the Bipolar definition. 
Research on the comorbidity of this disorder is still on-going. Biederman and associates 
have found that children with ADHD and Bipolar are more ill than children with just 
ADHD, and the children with both disorders have much higher rates of multiple 
hospitalizations. Controlled clinical trials of rtiood stabilizers in this population are not 
out yet. It has been found that the treatment regimes for these disorders can exacerbate 
each other. For instance, stimulants might increase mania whereas lithium can result in 
toxicity and need for close monitoring. The relationship between Bipolar and ADHD 
remains confusing and will require more time to determine whether there is any link 
between these two disorders.
Biederman and associates (1993) found that 53% of adults referred with ADHD 
met the criteria for at least two major Anxiety Disorders (Obsessive-Compulsive 
Disorder, Separation Disorder, Panic Disorder, Agoraphobia, Social Phobia, and 
Generalized Anxiety). When anxiety is present with ADHD, it intensifies the patient’s 
difficulties with self-esteem, adaptive functioning, working memory, and stress tolerance. 
Assessment of patients with ADHD and anxiety disorders can be complicated. It is 
common that both disorders have been present the entire life of the patient, therefore
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becoming embedded in a patient’s self-concept. As a result, anxiety is usually not self- 
reported unless the patient is specifically questioned in such a way that the anxiety 
becomes recognizable to the observer or clinician (Weiss et al., 1999).
Oppositional-Defiant Disorder (ODD), Conduct Disorder (CD), and Learning 
Disorders (LD) are also common with patients who have ADHD. ODD is defined as 
having problems with being stubborn, defiant, and angry whereas CD describes problems 
with getting into trouble, with such difficulties as fighting, stealing, breaking rules or fire 
setting. Learning disorders are often associated with higher rates of repeated grades, 
tutoring, placement in special classes, and reading disabilities. It is often thought that 
treatment of ADHD will place these other disorders into remission, which often is not the 
case. While some patients and families feel that the diagnosis of ADHD means that their 
child will be ODD, CD, or LD, this is by no means the case. Clinicians need to explain 
these other disorders to the patient so that they have realistic treatment outcomes.
Biederman et al. (1997) found that 52% of adults with ADHD had a lifetime 
history of substance abuse. Adults with ADHD are at three times the risk of smoking, but 
do not appear to be at a greater risk for alcohol abuse. Treatment of ADHD patients with 
substance abuse problems is a concern due to harmful effects that can occur if  patients 
mix stimulant medication with street drugs. There is considerable interest in developing 
better treatment for this population. Right now it is recommended that clinicians take a 
conservative approach when treating these patients.
Borderline Personality Disorder (BPD) is defined by feelings of emptiness, rage, 
mood instability, intense reactivity, self-destructive impulsivity, frantic efforts to avoid 
abandonment, unstable and intense interpersonal relationships, identity disturbances.
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intense anger and difficulty controlling anger, and paranoia. As in both BPD and ADHD, 
the patient’s behavior is puzzling to others because the patient functions so poorly.
Again, families and patients often think that treatment of one of these disorders will cure 
the other. Currently there are no published papers on the differential diagnosis between 
BPD and ADHD. Usually it is recommended that the BPD is treated as the primary 
disorder (Weiss et al., 1999).
Researchers have different views on the relationship of Tourette Syndrome (TS) 
and ADHD. Some believe that ADHD and TS may be one disorder. Others believe that 
they are not related. They feel that when the patient has to focus on suppressing the tics, 
it is the tics themselves which cause distractions for the patients and not necessarily the 
results of ADHD. There is currently only one unpublished adult ADHD/tic study done 
by Spencer, Coffey, and Biederman (described by Weiss et al., 1999). They looked at 
309 adults with ADHD and found that 11% have reported the presence of tics.
According to the reports by the patients, they believed that their ADHD started at about 
the age of 3 and the symptoms of tics started at average age of 12. Over 90% had 
experienced an onset of tics in childhood. This indicates that if a person has not had any 
tics by the age of 20 the likelihood of developing them as adults is very small. Most 
patients are taken off stimulants when tics appear due to the exacerbation of tics caused 
by the stimulants. It therefore is important for clinicians to get a good history especially 
from adults who may have had these types of side effects from medication when they 
were children (Weiss et al., 1999).
Further research is clearly necessary regarding the overlap with ADHD and other 
disorders. Differential diagnosis and comorbidity are the current frontiers of research in
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adult ADHD (Jensen, Martin, & Cantwell, 1997). These two areas are also the most 
difficult aspects of assessment and treatment of adult ADHD, because adults come to 
clinicians with a lifetime of untreated problems, making it even more complex to treat 
them compared to children. As many as one third of children with ADHD have one or 
more coexisting conditions. Children with ADHD should be assessed for coexisting 
conditions. A review of all coexisting conditions such as motor disabilities, problems 
with parent-child interaction, family violence. Conduct Disorder, Oppositional Defiant 
Disorder, Mood Disorders, Anxiety Disorders, and Learning Disorders should be 
included in the assessment. There are several screening tests available that can detect 
areas of concern for many of the mental health disorders that coexist with ADHD. Along 
with measures, the clinicians should also look at school performance for indicators of 
other coexisting problems.
Assessing Adults for ADHD
An outline that is considered the standard of care for adults who have or may have 
ADHD was recommended by The American Academy of Child and Adolescent 
Psychiatry (AACAP) in October of 1997 (Dulcan & Benson, 1997). This group of 
experts recognized that ADHD is a disorder beginning in childhood. These are the 
current recommended guidelines and mostly likely will not be replaced until the DSM-V 
is published. Therefore, the following procedures are necessary in diagnosing the adult 
manifestations of the disorder:
This outline is as follows:
I. Initial evaluation (a complete psychiatric assessment is indicated; see American 
Psychiatric Association Work Group on Psychiatric Evaluation of Adults [1995]).
A. Interview with patient.
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1. Developmental history.
2. Present and past DSM-IV symptoms of ADHD (may use 
symptoms or criterion checklist or self-report form).
3. History of development and context of symptoms and resulting 
past and present impairment.
a. School (learning, academic productivity, and behavior).
b. Work.
c. Family.
d. Peers.
4. History of other psychiatric disorders.
5. History of psychiatric treatment.
6. DSM-IV symptoms of possible alternate or comorbid 
psychiatric diagnoses, especially:
a. Personality disorder.
b. Mood disorders -depression or mania.
c. Anxiety disorders.
d. Dissociative disorder.
e. Tic disorder (including Tourette’s disorder).
f. Substance use disorder.
g. Learning disorders.
7. Strengths (e.g., talents and abilities).
8. Mental status examination.
B. Standardized rating scales completed by the patient’s parents.
C. Medical History.
1. Medical or neurological primary diagnosis (e.g., thyroid 
disease, seizure disorder, migraine, head trauma).
2. Medications that could be causing symptoms (e.g., 
phénobarbital, antihistamines, theophylline, sympathomimetics, steroids).
D. Family history.
1. Developmental and learning disorders.
2. Family coping style, level of organization, and resources.
3. Family stressors.
4. Abuse or neglect (as victim or perpetrator).
E. Interview with significant other or parent, if  available.
F. Physical evaluation.
1. Examination within 12 months or more recently if clinical 
condition has changed.
2. Further medical or neurological evaluation as indicated.
G. School information.
1. Standardized rating scales if completed during childhood.
2. Narrative childhood reports regarding learning, academic 
productivity, and behavior.
3. Reports of testing (e.g., standardized group achievement tests 
and individual evaluations).
4. Grades and attendance records.
H. Referral for additional evaluations if indicated.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
47
1. Psychoeducational evaluation.
2. IQ.
3. Academic achievement.
4. Learning disorders evaluation.
5. Neuropsychological testing.
6. Vocational evaluation.
II. Treatment planning.
A. Establish target symptoms of ADHD and baseline levels of 
impairment.
B. Consider treatment for comorbid conditions (monitor possible drug- 
seeking behavior).
C. Prioritize modalities to fit target symptoms and available resources.
D. Monitor multiple domains of functioning.
1. Academic or vocational.
2. Daily living skills.
3. Emotional adjustment.
4. Family interactions.
5. Social relationships.
6. Medication response.
E. Periodically reevaluate the efficacy of and need for additional 
interventions.
F. Maintain long-term supportive contact with the patient and family to 
ensure compliance with treatment and to address new problems that arise.
III. Treatment.
A. Education for patient, spouse, or other significant persons.
B. Consideration of vocational, counseling, or training.
C. Medication.
1. Stimulants.
2. Tricyclic antidepressants.
3. Other antidepressants.
4. Other drugs (buspirone, propranolol).
D. Psychosocial interventions. Individual cognitive therapy; “coaching.”
E. Family psychotherapy if  family dysfunction is present.
F. Referral to support group, such as CHADD.
G. Other treatments are outside the realm of the usual practice of 
psychiatry (The American Academy of Child and Adolescent Psychiatry [ACAP], 
1997, pp. I I I - I I2)
The American Academy of Child and Adolescent Psychiatry (AACAP) also 
recommends that a complete psychiatric evaluation be completed with particular attention 
to the core symptoms of ADHD (Dulcan & Benson, 1997). This evaluation will be 
helpful in determining if symptoms were present before the age of 7 years. Therefore, a
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childhood history is essential in making a diagnosis in an adult. Medical history and a 
recent physical examination with laboratory studies are necessary in order to rule out 
conditions that could be mistaken for ADHD.
There are several pre-printed guides clinicians can follow when taking history 
from an adult with ADHD. Russell Barkley (1990) has developed a four-page self-report 
form, which documents the patient’s development, employment, health, and social 
history. There is also an Adult Interview that provides a record of the patient’s family 
history, school history, and family psychiatric history. The Conners’ Adult ADHD 
history form was designed to be completed by the patient. This form is much more 
involved and is usually used as a guide for the clinician when interviewing patients. Tom 
Brown has designed the ADD Diagnostic Form. This form guides the clinician through 
all the components of an ADHD assessment including the interview, rating scales, 
psychological testing, review of the DSM-IV symptoms of ADHD, screening for 
comorbidity, and summarizing all of the information for the patient. Neuropsychological 
testing may be indicated to evaluate possible traumatic brain injury or a degenerative 
process (Dulcan & Benson, 1997).
Current Status of Treatments for ADHD
Despite the high media profile of the disorder in children, adult access to 
treatment remains quite limited. Previous beliefs were that children outgrew the disorder 
as they approached adulthood. Clinical training and research is now focusing on this 
disorder as aggressively as with children and adolescents (Shaffer, 1994).
Previous studies demonstrate that 76% of adults with ADHD will respond to 
treatment with stimulant medication, when treated with adequate doses (Spencer et al..
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1995; Wilens, Biederman, Spencer, & Prince, 1995). Surveys suggest that 166,416 new 
prescriptions for psychostimulants for individuals over 21 years of age were written in 
1992 and 227,367 in 1993. This represents a 37% increase in new prescriptions for 
adults. Even though there appears to be a clear predominance of adolescent males 
receiving prescriptions for ADHD, once a patient is older than 21 years, nearly as many 
women are treated with psychostimulants for ADHD.
Medication treatment has the same therapeutic effects, regardless of age. In the 
presence of comorbid substance use adults should be able to show abstinence for 1 month 
before starting medication treatment for ADHD. Target symptoms should be identified 
with clear baselines and repeated réévaluation to assess progress. Structured instruments 
are usually used to identify progress. Adults and children experience similar side effects, 
although adults seem to be more sensitive than children to stimulants (Spencer, 
Biederman, Wilens, & Faraone, 1994).
The common dosing range for methylphenidate is 20 to 80 mg a day, usually 
starting at 10 milligrams three times a day (Dulcan & Benson, 1997). For adults who 
need more frequent dosing, doctors are turning to the long-acting stimulants to alleviate a 
patient’s need to take numerous pills throughout the day and for a better effect of the 
medication. The long acting stimulants are usually dosed at 10 to 40 milligrams a day. 
Some adults have problems tolerating these medications due to the initial rapid 
absorption, which results in excessive side effects and can cause insomnia.
The empirically based benefits of psychosocial interventions are still unknown. 
Some clinicians feel that psychotherapy is not successful without pharmacotherapy.
Others believe that therapy should first identify the deficits as a result o f the ADHD and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
50
then make efforts to reduce self-blame and devise coping strategies. Cognitive 
remediation teaches techniques to enhance attention, memory, problem-solving, and 
family relationships. Coaching is sometimes used as this adjunctive treatment provides 
daily encouragement. Adults who have gone undiagnosed until late adulthood may need 
specific help in education, vocational skills, family therapy, or social skills (Dulcan & 
Benson, 1997).
Education about ADHD should be a core feature of the treatment plan. AACAP 
(Dulcan & Benson, 1997) recommends the following books and newsletters for adults to 
read: B. Ingersoll and S. Goldstein (1993), Attention Deficit Disorder and Learning 
Disabilities: Realities, Myths and Controversial Treatments', E.M. Hallowell and J.J. 
Ratey (1994), Driven to Distraction: Recognizing and Coping with Attention Deficit 
Disorder from Childhood Through Adulthood; E. M. Hallowell and J. J. Ratey (1994), 
Answers to Distraction, Attention! The Magazine o f Children and Adults with Attention 
Deficit Disorder; The ADHD Report; and Challenge: The First National Newsletter on 
Attention Deficit Disorder.
Support groups are also an important option to consider. Support groups can be a 
vital tool in providing information about ADHD, obtaining feedback to the patient about 
their treatment, and learning about updates in treatment. The advocacy group. Children 
and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), is often a good 
resource to start with when looking for a local support group.
Summary
Chapter 2 is divided into the following nine subheading: Overview and 
Prevalence of Attention Deficit Hyperactivity Disorder (ADHD), Impairments From
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ADHD, Factors That Influence an ADHD Diagnosis, History of ADHD Research, 
Manifestation of ADHD Symptoms, The DSM-IV Criteria for ADHD, ADHD and 
Comorbidity, Assessing Adults for ADHD, and Current Status of Treatments for ADHD. 
Each of the individual sections was designed to give the reader a global understanding of 
what is ADHD, what is currently known about it, the symptoms of ADHD, and how 
clinicians diagnose and treat this disorder.
Attention Deficit Hyperactivity Disorder is considered one of the most commonly 
diagnosed psychiatric disorders of children and adolescence (Dulcan & Benson, 1997). It 
is also believed that 1% to 2% of all adults have ADHD (Shekim et al., 1990). Adults 
and children manifest symptoms of ADHD very differently. ADHD typically refers to a 
developmental disorder of childhood characterized by persistent patterns of inattention 
and/or hyperactivity-impulsivity. These patterns usually occur at higher frequency and 
severity than typically observed in individuals of the same age and development 
(American Psychiatric Association, 1994; Conners & Jett, 2006). The symptoms must be 
present before the age of 7 years and should be seen across two different settings (e.g., 
home or school/work) for at least 6 months. It is also not enough to say that the 
symptoms are present, but there also must be evidence of a marked interference in the 
person’s social, academic, or occupational functioning. These “impairments” should not 
be better explained by other disorders, such as Pervasive Developmental Disorders, 
Schizophrenia, or any other Psychotic condition (American Psychiatric Association, 
1994).
ADHD is a chronic, lifetime disorder that takes a considerable toll on those 
suffering from it as well as the families and communities who care for these individuals.
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Significant proportions o f those with ADHD end up with serious social, emotional, 
interpersonal, and economic limitations. Currently no single cause of ADHD has been 
discovered. However, it is known that ADHD has strong genetic links, temperamental 
factors, neuropsychological factors, social and environmental risk factors, psychosocial 
variables (fetal alcohol syndrome, fetal or prenatal traumas, and narcotics), along with 
risks due to poverty, abuse, psychosocial trauma, or parental psychopathology.
Russell Barkley’s book (1990) Attention Deficit Hyperactivity Disorder: A 
Handbook for Diagnosis and Treatment provides a detailed historical perspective on 
ADHD along with existing research. According to Barkley’s book, ADHD symptoms in 
children were first written about in the 1900s. Currently, methylphenidate is the most 
commonly used stimulant in the treatment of ADHD. In 1957 the FDA approved 
Ritalin® for the treatment of hyperactivity, impulsivity, and inattention.
When clinicians make a diagnosis o f a patient they usually follow the standards 
set by the most current edition of the Diagnostic and Statistical Manual o f Mental 
Disorders-IV (DSM-IV). In October o f 1997 The American Academy of Child and 
Adolescent Psychiatry (AACAP) published their standard of care for adults who have or 
may have ADHD (Dulcan & Benson, 1997). The American Academy of Child and 
Adolescent Psychiatry (AACAP) also recommends that a complete psychiatric evaluation 
be completed with particular attention to the core symptoms of ADHD because 
comorbidity of ADHD with other psychiatric disorders can be as high as 77% (Weiss et 
al., 1999). It is therefore not enough for the clinician to know the criteria for the 
diagnosis of ADHD, the clinician must also be able to distinguish its symptoms from 
other conditions that may resemble ADHD. AACAP recommends that adult patients
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CHAPTER III 
METHODOLOGY 
Introduction
When a clinician uses a comprehensive diagnostic tool such as the CAADID to 
assess whether a patient has ADHD, he or she will be gathering information about the 
symptoms, the natural course, the past history, extent and degree of impairment of 
function, and response to previous treatments. When the patient himself or herself fills 
out rating scales regarding their symptoms, they are giving their own subjective report of 
their illness, without the filters provided by the expert clinician’s perspective. One would 
expect that the clinician and the patient should agree substantially regarding the 
symptomatic status, though plausibly not entirely to the same extent, since the clinician 
will be able to evaluate the symptoms in the context of much more experience. Both the 
patient’s subjective symptom report and the clinician’s fuller evaluation are important 
tools in the diagnosis.
Although verification of the diagnosis through the presence of symptoms is only 
one of the criteria to be fulfilled in making a diagnosis, it is obvious that the interview 
with an expert must show some congruence with the patient’s own subjective evaluation. 
Treatment plaiming also depends upon a good level of agreement between the clinician’s 
and patient’s view of the disorder. The symptoms are one of the markers to be assessed
54
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read books and newsletters about ADHD. They also advocate patients to attend support 
groups. Support groups can be a vital tool in providing information about ADHD, 
obtaining feedback to the patients about their treatment, and learning about updates in 
treatment.
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in determining whether a treatment is actually working (along with measures of 
functional impairment). Most clinicians acquire baseline information, 
from both the patient and an observer, regarding the severity of the patient’s symptoms. 
These baseline data are even more important if medication is being prescribed, so that 
doctors are better able to evaluate the effectiveness of the medication. If the patient and 
observer have significantly different rankings of the drug effect, not only is the baseline 
information misleading, but more importantly there is no substantial way to determine if 
the medication is having an effect on the symptoms. Therefore, this study will examine 
the correlation between the results of the CAARS (a self- and observer-rating scale) and 
the CAADID (a clinician comprehensive diagnostic interview).
Patient Sample
The sample for this research consists of adults between the ages of 18 and 60 
years of age. Clinical samples consistently show a 1:1 ratio of males to females among 
adult ADHD patients; this ratio is also present in this sample. The sample is from the 
United States and Canada. The following universities recruited patients from referrals to 
the ADHD clinics at each site; Yale University, New Haven, Connecticut; Duke 
University, Durham, NC; Children’s Hospital in Montreal, Montreal, Quebec, Canada; 
University o f Toronto, Toronto, Ontario, Canada; and the University of British Columbia, 
Vancouver, British Columbia, Canada.
One hundred and forty participants attended the initial baseline screening visit. 
Fifteen participants did not meet inclusion criteria, IS withdrew consent, and 9 were lost 
to follow-up. The final sample consisted of 98 adults with ADHD, of whom 64 remained 
enrolled for the entire 20 weeks. Of the 34 non-completers, 18 discontinued due to
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adverse events. Other reasons given for discontinuation included lack of treatment 
efficacy, protocol deviation, treatment non-compliance, lost to follow-up, and unknown 
reasons. Of the 98 patients, 59 were diagnosed with the Combined subtype and 39 were 
not. Fifty-nine were diagnosed with ADHD-Hyperactivity/Impulsive subtype and 39 
were not. Thus, the Hyperactive/Impulsive subtype group was compared against a group 
not diagnosed with that subtype; and the Combined subtype was compared with a group 
not diagnosed as Combined.
The participants in this study met the full DSM-IV criteria for at least one of the 
three subtypes of ADHD in adulthood as measured by a semi-structured clinical 
interview (CAADID) and self-report rating scales (CAARS). All patients had a good 
working knowledge of English and the capacity to comply with the demands of a 5- 
month treatment research project. Most patients had an observer rater (significant other) 
for the duration of the study. Current substance or alcohol abuse (i.e., in the last 3 
months), to a degree that significantly impairs function, or sufficient to eontraindicate use 
of psychotropic medication, is one exclusion criteria for participation in the study.
Patients with current eating disorders, organic brain syndromes (or other significant 
neurological diseases), or who are currently receiving treatment with other psychotropic 
medication were excluded. Those who have used an investigational drug within 30 days 
or 5 half-lives (a half-life is the point at which the drug reaches 50% of its peak 
concentration) were not enrolled in the study. Patients with a well-documented history of 
bipolar I, schizophrenic disorder, required hospitalization, or who are suicidal do not 
meet inclusion criteria.
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P ro c ed u res
Permission was obtained from the Ethics Review Committee (ERC)/Institutional 
Review Board (IRB) from Yale University, Duke University, Children’s Hospital in 
Montreal, University of Toronto, and the University of British Columbia. The protocol 
and all other materials related to the study (informed consent, advertising, etc.) were 
submitted to the appropriate committees or boards. These committees or boards then 
gave written unconditional approval before the commencement of the study. Permission 
was obtained from the Human Subjects Review Board, Office of Scholarly Research, at 
Andrews University (see Appendix A). Each patient received both oral and written 
informed consent as deemed appropriate by the ERC/IRB. Consent forms were in a 
language fully comprehensible to the prospective subject (see Appendix B).
The study was conducted according to Good Clinical Practice Guidelines and the 
Declaration of Helsinki (International Committee of Helsinki, n.d.). Good Clinical 
Practice (GCP) is an international ethical and scientific standard for designing, 
conducting, recording, and reporting trials that involve the participation of human 
subjects. The Declaration of Helsinki was developed by The World Medical Association 
as a statement of ethical principles to guide medical research involving human subjects. 
The guidelines were adopted in Helsinki, Finland.
Instrumentation
For this research project, only data from two of the instruments or scales were 
utilized, the Conners’ Adult ADHD Diagnostic Interview for DSM-IV (CAADID) and the 
Conners’ Adult ADHD Rating (CAARS) (see Appendix C, D, E, F, and G). The 
CAADID and CAARS were used in this study exactly as they were published. No
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modifications were made to the scales’ response range, categories, or scoring criteria. 
Permission to copy the scales for this research was received from Dr. Conners, the author 
of the scales (see Appendix H). Each university had either their M.D. or Ph.D. 
administer the CAADID to the patient. To assure that each university was able to 
provide uniformity of the administration of the CAADID, each university had to have a 
well-established ADHD clinic, had previous research experience with established active 
clinical trial projects, and long patient waiting lists. The authors of the CAADID 
provided overall supervision either through site visits or conference calls. Each site had 
to provide in-house supervision from experts in the field of ADHD (Thomas Brown, 
Ph.D.; Lily Hectman, M.D.; Umesh Jain, M.D.; Diane Johnson, Ph.D.; Keith Conners, 
Ph.D.; Donald Quinlan, Ph.D.; and Margaret D. Weiss, M.D., Ph.D.). This assured 
uniformity across sites regarding the administration of the CAADID. All of the sites 
were given the CAADID manual which contains instruction on the administration. In 
addition to this, pre-study pilot rehearsals were completed with each site.
Conners’ Adult ADHD Diagnostic Interview for DSM-IV
The Conners’ Adult ADHD Diagnostic Interview fox DSM-IV (CAADID) was 
published in 2001 by Multi-Health Systems (MHS) in order to provide clinicians both a 
current and past history of ADHD symptoms and diagnostic information based on the 
DSM-IV. CAADID is divided into Part I and Part II. Each part takes about 1.5 hours to 
complete. The CAADID was developed by the following three researchers who are 
experts in the field of ADHD: Diane E. Johnson, Ph.D.; C. Keith Conners, Ph.D.; and 
Jeff Epstein, Ph.D. The researchers addressed current problems regarding the assessment 
of adult ADHD through the development of this scale.
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There is a potential for over-diagnosis and misclassification when assessing adults 
for ADHD. In adults, behaviors can mimic ADHD symptoms due to the aging process. 
Throughout the CAADID interview a reminder is embedded so the clinician has 
guidelines to determine if the patient’s behaviors occur to a greater degree than the 
patient’s peers. Each time a patient endorses a symptom, the clinician also is to gather 
individual patient information about the behavior in order to make a clinical judgment as 
to whether the symptom is really present.
ADHD adults often have a higher rate of comorbid disorders than children with 
ADHD. Some comorbid disorders have symptoms quite similar to those of ADHD. 
Therefore, the CAADID’s comprehensive interview assesses other disorders so an 
accurate diagnosis can be made. The following is an abbreviated list o f other conditions 
that are examined: Schizophrenia, Bipolar Disorder, Cyclothymia, Depression (with 
agitation). Anxiety Disorders, Antisocial Personality Disorder, Borderline Personality 
Disorder, alcoholic intoxication or withdrawal, other substance abuse disorders. 
Intermittent Explosive Disorder, Dissociative Disorder, Posttraumatic Stress Disorder, 
Conduct Disorder, Learning Disorders, age-appropriate high activity. Mental Retardation, 
stress/environment, head injury. Dementia, Delirium, Tumors, Tourette’s Disorder,
Stroke, Hyperthyroidism, Renal Insufficiency, Hepatic Insufficiency, Anoxic 
Encephalopathy, vitamin deficiency state. Chronic Obstructive Pulmonary Disease, 
Multiple Sclerosis, Seizures/Epilepsy, sensory deficits, drug side effects, and 
neurological disorders of vigilance.
ADHD symptoms can also be a result of an adverse environment. Part I of the 
CAADID assesses psychosocial stressors and their impact on the adult’s life. This is
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particularly helpful to the clinician in tracking the symptoms over time as treatment 
progresses. The last two issues in assessment involve the limits of the adult ADHD 
assessment as it relates to the DSM-IV.
The DSM-IV lists ADHD behaviors as they relate to childhood ADHD symptoms. 
The CAADID has been translated from the childhood behaviors into terms more 
appropriate to adulthood. Besides just listing the translated list of behaviors, the 
CAADID also contains a list of the original child symptoms, thus helping clinicians to 
judge whether current behaviors are consistent with the intent of the childhood versions 
of the symptoms. The last issue is getting a retrospective symptomatic history, which can 
be difficult, since the onset of the symptoms must be present by the age of 7. The 
CAADID has been developed so that simultaneous diagnoses of ADHD in adulthood and 
childhood can be made. If symptoms are present the interview then establishes the age of 
onset of these symptoms. The patient usually completes Part I on his or her own, prior to 
meeting with the clinician. Part I provides the clinician with a comprehensive 
demographic and developmental history. Many of the questions in Part I will require 
follow-up interviews by the clinician. It is recommended that Part I not be used with 
patients who are disoriented, severely impaired, or who have poor reading abilities in 
order to assure the accuracy of the information.
Part I is divided into Demographic information and several risk factors, including: 
(a) Gestation (h) Delivery; (c) Temperament; (d) Developmental; (e) Environmental; (f) 
Medical; and (g) Academic. Psychiatric, Family, Educational, Occupational, 
Social/Interpersonal, Health, Adult Psychological/psychiatric, and Comorhidity 
Screening Questions are also included. Because ADHD does not have a single cause of
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its pathology, the different risk factors are usually examined when assessing for ADHD. 
If a patient screens positive for other comorbidities, then it is suggested that an additional 
comprehensive psychopathology interview (the SCDD) be completed to assess significant 
comorbid conditions.
Part II focuses on the DSM-IV criteria across age spans. Part II is completed by 
the clinician with the patient present. A trained interviewer with an advanced degree in 
psychology, psychiatry, or social work administers Part II. Part II is divided into three 
sections. The first section assesses the presence of Inattention symptoms per the DSM- 
IV, followed by questions of the onset of these symptoms. The second section assesses 
the hyperactive-impulsive symptoms and their onset and the level of impairment created 
by each symptom. The third section is a summary sheet and scoring algorithm that 
enables the clinician to synthesize all the information for Part II to make a DSM-IV 
diagnosis. Items in Part I of the CAADID have been numbered to facilitate cross 
referencing of information. In Part II, instead of numbers, an alphabetical code is used. 
An algorithm is then used to chart the answers J&om Part I and II in order for the clinician 
to make a diagnosis based on clinical judgment. In other words the CAADID simplifies 
and organizes a wealth of patient information which is then used by the clinician to make 
his/her diagnoses. This ensures that the same information and diagnostic criteria are used 
across different clinicians.
The CAADID was chosen for use in this study due to its very recent development. 
There is no statistical information in the manual regarding validity o f the CAADID. In 
fact, the manual states that the researchers would be appreciative of having additional 
data on CAADID in order to further the psychometric development o f this measure. This
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study utilizes data from the assessment phase of a carefully conducted clinical trial to 
further this aim.
Conners’ Adult ADHD Rating Scales
The Conners’ Adult ADHD Rating Scales (CAARS) was published in 1999 by 
Multi-Health Systems (MHS) (Conners, Erhardt, Sparrow, et al., 1998). The scale draws 
information on the patient’s symptoms from three sources, either the patient’s self-report; 
or a report completed by a family member or coworker who has been in recent 
observable contact with the patient; or a short screening version filled out by a doctor. 
There are several versions of the CAARS. For this study the CAARS Self-Report Long 
Version, Observer Report Long Version, and the Observer Report: Screening Version 
were used. The authors of the CAARS are Keith Conners, Ph.D., Drew Erhardt, Ph.D., 
and Elizabeth P. Sparrow, M.A. (Conners, Erhardt, Sparrow, et al., 1998; Conners et al., 
1999).
The authors indicated that there were several reasons why the development of 
these scales came about. While there are many scales for assessing childhood ADHD, 
there was a paucity of carefully developed scales for adults. There was no symptom list 
validated against norms collected from adults. It is more difficult to assess adults, as 
contrasted with children, because of the accumulated “emotional baggage” experienced 
by adults. The expression of the disorder in adults appears to be different from what 
clinicians see in children with ADHD. For example, adults may no longer be 
hyperactive, but they often feel an inner restlessness. In addition, the cognitive 
limitations of the adult patient are more complex, revealing the primary deficits of
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“executive function” that may have been masked in a protective and structured childhood 
environment.
As outlined in the technical manual, the main features of the CAARS are as 
follows:
1. A large normative database (N -  2,000)
2. Scales that assess ADHD and related symptoms and behaviors
3. Matching forms for self-report and observer ratings
4. Clinical and diagnostic relevance
5. Long and short versions
6. ADHD Index, containing the items that best distinguish individuals with 
ADHD from non-clinical individuals
7. Scales match the D5M-/F criteria for ADHD
8. Easy administration, scoring, and profiling of results
9. Graphs to monitor progress
10. Excellent reliability and validity
11. Applicable in managed-care situations.
The CAARS was also developed out of the need for standardized self-ratings 
from adults undergoing evaluation for ADHD. The authors of the CAARS first started 
with the creation of an item pool that tapped a cross-section of symptoms related to adult 
ADHD. Ninety-three items were derived from the DSM-IV symptom criteria for ADHD, 
the Conners’ Rating Scales-Revised for Children and Adolescents, and current 
conceptions for adult ADHD. These 93 items were then used to develop the following 
nine hypothesized ADHD domains on the CAARS; (a) inattention/problems with
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concentration; (b) hyperactivity/restlessness; (c) impulsivity/problems with self-control; 
(d) problems with executive functioning (tapping difficulties with self-regulation, 
organization, prioritization, time awareness, and planning that interferes with the ability 
to accomplish higher level tasks in an efficient manner); (e) problems with memory; (f) 
problems with self-concept; (g) interpersonal problems; (h) problems with learning; and 
(i) problems with mood (including poor frustration tolerance, irritability, and emotional 
lability) (Conners, Erhardt, Sparrow, et ah, 1998).
The 93 items were administered to 839 non-clinieal adults (444 males, 394 
females) ranging in age from 18 to 81 years. The mean age for the men was 39.6 and 
38.8 for the women. A series of factor analyses was conducted to determine which items 
should be retained on the final version, thus creating the four factor-derived scales that 
are used on the CAARS: Inattention/Memory Problems, Hyperaetivity/Restlessness, 
Impulsivity/Emotional Lability, and Problems with Self-Concept. The ADHD Index was 
developed to provide a method of identifying those adults who are likely to be diagnosed 
with ADHD. A sample o f 39 adults (23 males and 16 females) who met the DSM-IV 
eriteria of ADHD and 39 non-clinical adults were used to determine this Index. On the 
basis of a series of /-test analyses, 30 items from the item-pool were originally identified 
as items that discriminate between the ADHD and non-clinical groups. After a series of 
analyses, 12 items remained that were found to be the best predictor of adult ADHD and 
were therefore selected to be used as the ADHD Index on the CAARS.
As noted in the manual, the CAARS Self-Report and Observer forms were 
developed over several years. Norms were taken fi-om a large sample o f non-clinical 
adults from several locations in the United States and Canada. A large pool of items
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assessed a cross-section of symptoms relevant to adult ADHD. The results were then 
normed and analyzed further for validity and reliability, as outlined in several chapters of 
the manual and in publications (Conners, Erhardt, Epstein, et ah, 1998). The CAARS 
Self-Report Form can be administered to adults 18 years of age and older. The CAARS 
Observer-Report: Long & Screening Form can basically be given to anyone who has 
regular contact with the patient such as a family member, teacher, coworker, or clinician. 
Both self-report and observer forms use a 4-point Likert-style format (0=Not at all, never; 
1-just a little, once in a while; 2=Pretty much, often; 3 = Very much, very frequently). 
Respondents are asked to rate items pertaining to behavior problems. Each of the short 
scales takes about 10 minutes to administer, and the long scales take less than 30 minutes. 
The CAARS can be administered individually or in groups. An administrator should 
almost always be present when the respondent is completing the form. The manual does 
an excellent job going over nine steps that the authors recommend should be followed 
when administering the CAARS. Scoring each scale will rarely require more than 10 
minutes by hand and only a few seconds with the computer program. The CAARS 
comes with a profile form that allows for the visual display of scores and comparisons 
with an appropriate normative group. Raw scores are converted to ^-scores and no 
templates are needed to score individual forms.
Both the CAARS Self-Report: Long Version and the CAARS Observer-Report: 
Long Version have 66 items and nine subscales. These two scales have four factor- 
derived scales that assess a cross-section of ADHD-related symptoms and behaviors as 
listed as follows: a 12-item Inattention/Memory Problems subscale, a 12-item 
Hyperactivity/Restlessness subscale, a 12-item Impulsivity/Emotional Lability subscale.
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and a 6-item Problems with Self-Concept subscale. The scales contain three DSM-IV 
ADHD symptom measures that assess ADHD symptoms according to the criteria listed in 
the DSM-IV. A 12-item ADHD Index is also included on the long forms. This index 
contains the best set of items for distinguishing ADHD adults from patients who are not 
symptomatic. Another scale contained in the CAARS long forms is the Inconsistency 
Index, for identifying random or careless responding.
In order to interpret the CAARS, one should have a general understanding of 
ADHD as well as knowledge of administering standardized tests. The manual goes over 
“faking bad” and “faking good.” Indicators are given to the clinician if  they suspect that 
the responders are not reliable and valid. CAARS raw scores are transformed into T- 
scores. T-scores have a mean of 50 and a standard deviation of 10.
When interpreting the CAARS, the clinician will want to examine the pattern of 
elevated scale scores in addition to considering individual T-scores. If there are no T- 
scores above 65, it is indicative that the patient is not displaying any clinically elevated 
symptoms of ADHD. When one T-score is above 65, the pattern is marginal. The 
greater the number of scales that show clinically relevant elevations (T-score above 65), 
the greater the likelihood that the patient is indicating moderate to severe problems with 
ADHD (Conners, Erhardt, Sparrow, et ah, 1998).
The technical manual recommends six steps when interpreting the CAARS.
1. Review the scale to make sure that the results are valid. Inspect the CAARS 
Inconsistency Index to estimate whether the pattern of item responses is internally 
consistent. Also make sure it is consistent with the response patterns shown by other 
individuals of the same age and gender.
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2. Review the individual items. Make notes using the items by subscale in 
Appendix B in the manual. This is helpful in both tracking elevated scores and making a 
treatment plan.
3. Review the ADHD Index (the ADHD index represents a measure of the 
overall level of ADHD-related symptoms), the three DSM-IV ADHD symptom subscales, 
and the four factor-derived subscales. Norms are given for population samples on this 
Index so patients’ symptoms can be scored. The DSM-IV ADHD scales on the long and 
screening forms can also be used to identify adults experiencing clinically significant 
levels of ADHD. The four factor-derived subscales are as follows;
a. Inattention/Memory Problems: Learn more slowly, have problems 
organizing and completing tasks, and have trouble concentrating.
b. Hyperactivity/Restlessness: Have difficulty working at the same task 
for very long and feel more restless and “on the go” than others.
c. Impulsivity/Emotional Lability: Engage in more impulsive acts than 
others, moods change quickly and often and are more easily angered and 
irritated by people.
d. Problems with Self-Concept: Have poor social relationships, low self­
esteem, and low self-confidence.
The third interpretation guideline recommends a comprehensive review of all the 
information so a plan can be developed to help the patient.
4. The guideline recommends integrating the information from the self-report and 
observer forms.
5. Use other clinical information gathered during the patient’s intake interview.
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6. After considering all of the information, make an individualized treatment plan 
(Conners. Erhardt, Sparrow, et ah, 1998).
The main difference between the CAARS scales described above and the CAARS 
Observer-Report: Screening Version is that that screening version has 30 items, uses the 
DSM-IV items, and does not include the factor scores. Table 1 outlines the differences 
between the three versions of the CAARS (all of which were also all used for this study).
Research Questions
Research Questions 1 : Is there a difference in the mean score on the CAARS as 
rated by the patient between those patients who have been diagnosed, according to the 
CAADID, as Hyperactive/Impulsive subtype of ADHD compared to those who have not? 
Research Questions 2: Is there a difference in the mean score on the CAARS as rated by 
the observer between those patients who have been diagnosed, according to the 
CAADID, as Hyperactive/Impulsive subtype of ADHD compared to those who have not?
Research Questions 3: Is there a difference in the mean score on the CAARS as 
rated by the doctor between those patients who have been diagnosed, according to the 
CAADID, as Hyperactive/Impulsive subtype of ADHD compared to those who have not?
Research Questions 4: Is there a difference in the mean score on the CAARS as 
rated by the patient between those patients who have been diagnosed, according to the 
CAADID, as Combined subtype of ADHD compared to those who have not?
Research Questions 5: Is there a difference in the mean score on the CAARS as 
rated by the doctor between those patients who have been diagnosed, according to the 
CAADID, as Combined subtype of ADHD compared to those who have not?
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Research Questions 6\ Is there a difference in the mean score on the CAARS as 
rated by the observer between those patients who have been diagnosed, according to the 
CAADID, as Combined subtype of ADHD compared to those who have not?
Table 1
CAARS Versions: Number o f Items and Factors
Name of Scale Abbreviation Number 
of Items
Factors Measured
CAARS Self- 
Report: Long 
Version
CAARS-S:L 66 Factor Derived Subscales: 
Inattention/Memory Problems 
Hyperactivity/Restlessness 
Impulsivity 
Emotional Lability 
Problems with Self Concept 
DSM-IV ADHD Symptom Subscales: 
Inattentive Symptoms 
Hyperactive-Impulsive Symptoms 
Total ADHD Symptoms
CAARS 
Observer- 
Report: Long 
Version
CAARS-0:L 66 Factor Derived Subscales: 
Inattention/Memory Problems 
Hyperactivity/Restlessness 
Impulsivity 
Emotional Lability 
Problems with Self Concept 
DSM-IV ADHD Symptom Subscales: 
Inattentive Symptoms 
Hyperactive-Impulsive Symptoms 
Total ADHD Symptoms
CAARS
Observer-
Report:
Screening
Version
CAARS-0:S 30 DSM-IV ADHD Symptom Subscales: 
Inattentive Symptoms 
Hyperactive-Impulsive Symptoms 
Total ADHD Symptoms
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The following statements are hypotheses that have emerged from the research 
questions.
Null Hypotheses
1. There will be no difference between the mean CAARS ratings by the patient 
for Hyperactive/Impulsive symptoms for groups diagnosed by the CAADID as ADHD 
Hyperactive/Impulsive subtype versus those not diagnosed with ADHD Hyperactive/ 
Impulsive subtype.
2. There will be no difference between the mean CAARS ratings by the doctor of 
ADHD Hyperactive/hnpulsive symptoms for groups diagnosed by the CAADID as 
ADHD Hyperactive/Impulsive subtype versus those not diagnosed with ADHD 
Hyperactive/Impulsive subtype.
3. There will be no difference between the mean CAARS ratings by the observer 
for Hyperactive/Impulsive symptoms for groups diagnosed by the CAADID as ADHD 
Hyperactive/Impulsive subtype versus those not diagnosed with ADHD Hyperactive/ 
Impulsive subtype.
4. There will be no difference between the mean CAARS ratings by the patient 
for Combined symptoms for groups diagnosed by the CAADID as ADHD Combined 
subtype and not diagnosed with ADHD Combined subtype.
5. There will be no difference between the mean CAARS ratings by the doctor 
for Combined symptoms for groups diagnosed by the CAADID as ADHD Combined 
subtype and not diagnosed with ADHD Combined subtype.
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6. There will be no difference between the mean CAARS ratings by the observer 
for Combined symptoms for groups diagnosed by the CAADID as ADHD Combined 
subtype and not diagnosed with ADHD Combined subtype.
Data Analysis
Patients were diagnosed by the CAADID as having either a sub-type of ADHD or 
not having it. Qualitative methods were used via the CAADID, in which a series of 
questions was asked in order to separate the sample into two groups: those with a 
CAADID diagnosis of Combined or Hyperactive/Impulsive subtype and those without a 
CAADID diagnosis of Combined or Hyperactive/Impulsive subtype. The rating scales 
(CAARS) are quantitative, that is, the scores vary along a continuum of numbers from 0 
to 100. The difference between the diagnosed groups and not diagnosed groups on each 
of the CAARS Rating Scales was examined by Mest, a statistical test of difference 
between two means. The difference is expressed as a probability. For this study, 
probability is considered significant when it is less then 0.05.
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DATA ANALYSIS
Purpose
The purpose of this study was to compare the results from two different adult 
ADHD tools: the CAARS, a normed instrument for assessing symptoms of ADHD; and 
the CAADID, a diagnostic interview covering the formal criteria for diagnosis of ADHD.
Characteristics of the Sample
The overall study, of which this study is a part, was sponsored by an educational 
grant from Smith-Kline Beecham, entitled Treatment o f  Adults With Attention Deficit 
Hyperactivity Disorder and Varying Degrees o f  Anxiety and Depressive Symptoms. One 
hundred and eight patients between the ages o f 18 and 60 years of age were initially 
recruited for the study. Out of the 108 patients, 98 enrolled in the study and completed 
the baseline data.
Table 2 shows the gender, age, and ethnicity makeup of the total sample. The 
oldest participants in the study were African American females with a mean age of 49 
years, while Asian men were the youngest with a mean age o f 26 years. The total sample 
of both males and females had a mean age of 37 years. On average, African American 
females were 49 years of age, Caucasian females were 39 years o f age, and the Asian 
female was 37 years of age. The mean age of Hispanic men was 43 years, Caucasian
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males were 37 years, unspecified ethnic males were 29 years, and Asian males were 26 
years.
There were a total of 83 Caucasians, 8 Others (Arabic, South Pacific, etc.), 1 
Hispanic, 3 Asians, and 3 African Americans in the study population. Caucasian males 
comprised the majority of the study sample with a size of 52. Hispanic males and Asian 
females had the smallest sample size of 1 each. There were 3 African American females 
in the study and no African American males. Only 1 Hispanic male enrolled, with no 
Hispanic female enrollment taking place in the study. Fifty-two Caucasian males and 31 
Caucasian females were in the study. Two Asian males and 1 Asian female participated 
in the study. There were 8 participants of other ethnic backgrounds. All 8 were males 
with no female study patients.
Findings
Research Question 1. Is there a difference in the mean score on the CAARS as 
rated by the patient between those patients who have been diagnosed, according to the 
CAADID, as Hyperactive/Impulsive subtype of ADHD compared to those who have not?
Null Hypothesis 1. There will be no difference between the mean CAARS ratings 
by the patient for Hyperactive/hnpulsive symptoms for groups diagnosed by the 
CAADID as ADHD Hyperactive/hnpulsive subtype versus those not diagnosed with 
ADHD Hyperactive/Inattentive subtype.
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Table 2
Ethnicity Demographics
Ethnicity Gender Patient Number Mean Age in Years
African American Male 0
African American Female 3 49
Hispanic Male 1 43
Hispanic Female 0
Other Male 8 29
Other Female 0
Caucasian Male 52 37
Caucasian Female 31 39
Asian Male 2 26
Asian Female 1 37
Total Sample Male & Female 98 37
Interpretation of Table 3
Table 3 presents data from two groups of patients. One group was adult patients 
diagnosed with ADHD Hyperactive/hnpulsive Subtype using the CAADID. The other 
group of patients had been diagnosed with ADHD but not the subtype of 
Hyperactive/hnpulsive. The data compare the mean scores of the two diagnostic groups 
using the CAARS self-report of symptoms from the patient. The data indicate that the 
mean score of the Hyperactive/hnpulsive subtype is significantly higher than the mean 
score of the non-Hyperactive/hnpulsive group. The significantly higher mean (average) 
score indicates that the Hyperactive/hnpulsive patients rate themselves higher (have more 
symptoms) than the other group. The two groups have a mean difference in scores that
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would occur by chance less than one time in ten thousand. Therefore the null hypothesis 
that the two means would not differ was rejected.
Table 3
CAADID Diagnosis o f Hyperactive/Impulsive Subtype and CAARS Ratings o f 
Hyperactivity/Impulsivity fo r  the Self Rater
ADHD PT’s DX by ADHD PT’s not DX
CAARS RATER the CAADID as by the CAADID as
Hyperactive/Impulsive having
Sub-Type (N= 59) Hyperactive/Impulsive 
Sub-Type (N=  36)
Mean SD Mean SD t-test p
Self 68.30 11.4 56.5 13.2 4.61 .000
Note. Dx = Diagnosis. Two-tail f-test of mean differences considered Non Significant 
(NS) if the probability is greater than 0.05.
Research Question 2. Is there a difference in the mean score on the CAARS as 
rated by the doctor between those patients who have been diagnosed, according to the 
CAADID, as Hyperactive/Impulsive subtype of ADHD compared to those who have not?
Null Hypothesis 2. There will be no difference between the mean CAARS ratings 
by the doctor of ADHD Hyperactive/Impulsive symptoms for groups diagnosed by the 
CAADID as ADHD Hyperactive/Impulsive subtype versus those not diagnosed with 
ADHD Hyperactive/Impulsive subtype.
Interpretation of Table 4
Table 4 presents data from two groups of patients. One group was adult patients 
diagnosed with ADHD Hyperactive/hnpulsive Subtype using the CAADID. The other
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group of patients had been diagnosed with ADHD but not the subtype of 
Hyperactive/Impulsive. The study doctor was asked to complete the CAARS regarding 
his/her observation of the patient’s symptoms by the doctor. The data compare the mean 
scores of the two diagnostic groups using the CAARS screening report of symptoms.
The data indicate that the mean score of the Hyperactive/Impulsive subtype is 
significantly higher than the mean score of the non-Hyperactive/Impulsive group. The 
significantly higher mean (average) score indicates that the Hyperactive/Impulsive 
patients had more symptoms than the other group. The two groups have a mean 
difference in scores that would occur by chance less than one time in ten thousand. 
Therefore the null hypothesis that the two means are the same was rejected.
Table 4
CAADID Diagnosis o f Hyperactive/Impulsive Subtype and CAARS Ratings o f 
Hyperactivity/Impulsivity fo r  the Screening (doctor) Rater
ADHD PT’s DX by the ADHD PT’s not DX
CAARS RATER CAADID as by the CAADID as
Hyperactive/Impulsive having
Sub-Type {N= 60) Hyperactive/Impulsive
Sub-Type (A== 35)
Mean SD Mean SD t-test p
Doctor (Screener 53.55 8.9 43.81 8.9 5.13 .000
Version)
Note. Dx = Diagnosis. Two-tail t-test of mean differences considered Non Significant 
(NS) if the probability is greater than 0.05.
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Research Question 3. Is there a difference in the mean score on the CAARS as 
rated by the observer between those patients who have been diagnosed, according to the 
CAADID, as Hyperactive/Impulsive subtype of ADHD compared to those who have not?
Null Hypothesis 3. There will be no difference between the mean CAARS ratings 
by the observer for Hyperactive/Impulsive symptoms for groups diagnosed by the 
CAADID as ADHD Hyperactive/Impulsive subtype versus those not diagnosed with 
ADHD Hyperactive/Impulsive subtype.
Interpretation of Table 5
Table 5 presents data from two groups of patients. One group was adult patients 
diagnosed with ADHD Hyperactive/Impulsive Subtype using the CAADID. The other 
group of patients had been diagnosed with ADHD but not the subtype of 
Hyperactive/Impulsive. The observer (the patient’s significant other) was asked to 
complete the CAARS regarding his/her observation of the patient’s symptoms. The data 
compare the mean scores of the two diagnostic groups using the CAARS screening report 
of symptoms. The data indicate that the mean score of the Hyperactive/hnpulsive 
subtype is significantly higher than the mean score of the non-Hyperactive/Impulsive 
group. The significantly higher mean (average) score indicates that the 
Hyperactive/hnpulsive patients had more symptoms than the other group. The two 
groups have a mean difference in scores that would occur by chance less than eight times 
in a thousand. Therefore the null hypothesis that the two means would not differ was 
rejected.
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Table 5
CAADID Diagnosis o f Hyperactive/Impulsive Subtype and CAARS Ratings o f  
Hyperactivity/Impulsivity for the Observer Rater
ADHD PT’s DX by ADHD PT’s not DX
CAARS RATER the CAADID as by the CAADID as
Hyperactive/Impulsive having
Sub-Type (# =  58) Hyperactive/Impulsive 
Sub-Type (A^= 31)
Mean SD Mean SD t-test p
Observer 60.29 12.68 52.52 12.95 2.74 .008
Note. Dx = Diagnosis. Two-tail t-test of mean differences considered Non Significant 
(NS) if the probability is greater than 0.05.
Research Question 4. Is there a difference in the mean score on the CAARS as 
rated by the patient between those patients who have been diagnosed, according to the 
CAADID, as Combined subtype of ADHD compared to those who have not?
Null Hypothesis 4. There will be no difference between the mean CAARS ratings 
of the ADHD Combined subtype by the patient for groups diagnosed by the CAADID as 
ADHD Combined subtype and not diagnosed with ADHD Combined subtype.
Interpretation of Table 6
Table 6 presents data from two groups of patients. One group was adult patients 
diagnosed with ADHD Combined Subtype using the CAADID. The other group of 
patients had been diagnosed with ADHD but not the subtype of Combined. The data 
compare the mean scores of the two diagnostic groups using the CAARS self-report of 
symptoms. The data indicate that the mean score o f the Combined subtype is 
significantly higher than the mean score of the non-Combined subtype group. The 
significantly higher mean (average) score indicates that the Combined subtype patients
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rate themselves higher (have more symptoms) than the other group. The two groups have 
a mean difference in scores that would occur by chance less than three times in a 
thousand. Therefore the null hypothesis that the two means would not differ was 
rejected.
Table 6
CAADID Diagnosis o f Combined Subtype and CAARS Ratings o f  the Combined Subtype
for the Self Rater__________________________________________________________
ADHD PT’s DX by the ADHD PT’s not DX 
CAARS RATER CAADID as Combined by the CAADID as
Sub-Type (A = 59) Combined Sub-Type
(A = 39)
Mean_______SD______ Mean______SD t-test p
Self__________________78.93 10.78 71.68 12.13 3.05 .003
Note. Dx = Diagnosis. Two-tail t-test of mean differences considered Non Significant 
(NS) if the probability is greater than 0.05.
Research Question 5. Is there a difference in the mean score on the CAARS as 
rated by the doctor between those patients who have been diagnosed, according to the 
CAADID, as Combined subtype of ADHD compared to those who have not?
Null Hypothesis 5. There will be no difference between the mean CAARS ratings 
of the ADHD Combined subtype by the doctor for groups diagnosed by the CAADID as 
ADHD Combined subtype and not diagnosed with ADHD Combined subtype.
In te rp re ta tio n  o f  T ab le  7
Table 7 presents data from two groups of patients. One group was adult patients 
diagnosed with ADHD Combined Subtype using the CAADID. The other group of
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patients had been diagnosed with ADHD but not the subtype of Combined. The study 
doctor was asked to complete the CAARS regarding his/her observation of the patient’s 
symptoms. The data compare the mean scores of the two diagnostic groups using the 
CAARS screening report of symptoms. The data indicate that the mean score of the 
Combined subtype is significantly higher than the mean score of the non-Combined 
subtype group. The significantly higher mean (average) score indicates that the 
Combined subtype patients had more symptoms than the other group . The two groups 
have a mean difference in scores that would occur by chance less than one time in a 
thousand. Therefore the null hypothesis that the two means would not differ was 
rejected.
Table 7
CAADID Diagnosis o f  Combined Subtype and CAARS Ratings o f  the Combined Subtype 
for the Screening (doctor) Rater
CAARS RATER
ADHD PT’s DX by 
the CAADID as 
Combined Sub-Type 
(A =58)
ADHD PT’s not 
DX by the 
CAADID as 
Combined Sub- 
Type (A= 39)
Mean SD Mean SD /-test P
Doctor (Screener 
Version)
52.64 9.91 45.69 8.78 3.48 0.001
Note. Dx = Diagnosis. Two-tail /-test of mean differences considered Non Significant 
(NS) if  the probability is greater than 0.05.
Research Question 6. Is there a difference in the mean score on the CAARS as 
rated by the observer between those patients who have been diagnosed, according to the 
CAADID, as Combined subtype of ADHD compared to those who have not?
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Null Hypothesis 6. There will be no difference between the mean CAARS ratings 
of the ADHD Combined subtype by the observer for groups diagnosed by the CAADID 
as ADHD Combined subtype and not diagnosed with ADHD Combined subtype.
Interpretation of Table 8
Table 8 presents data from two groups of patients. One group was adult patients 
diagnosed with ADHD Combined Subtype using the CAADID. The other group of 
patients had been diagnosed with ADHD but not the Combined subtype. The study 
observer (the patient’s significant other) was asked to complete the CAARS regarding 
his/her observation of the patient’s symptoms. The data compare the mean scores of the 
two diagnostic groups using the CAARS screening report of symptoms. The data 
indicate that the mean score of the Combined subtype is not significantly higher than the 
mean score of the non-Combined subtype group. The non-significantly higher mean 
(average) score indicates that the Combined subtype patients did not have more 
symptoms than the Non-Combined subtypes. The two groups have a mean difference in 
scores that is well below the critical value for the t-test, and is therefore non-significant. 
Therefore the null hypothesis that the two means would not differ was accepted.
Summary
The purpose of this study was to compare the results from two different adult 
ADHD tools; the CAARS, a normed instrument for assessing symptoms of ADHD; and 
the CAADID, a diagnostic interview covering the formal criteria for diagnosis of ADHD, 
including confirmation of a childhood diagnosis of ADHD.
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Table 8
CAADID Diagnosis o f  Combined Subtype and CAARS Ratings o f the Combined Subtype 
for the Observer Rater
ADHD PT’s DX by ADHD PT’s not
CAARS RATER the CAADID as 
Combined Sub-Type 
(/V=59)
DX by the 
CAADID as 
Combined Sub- 
Type {N=  39)
Mean SD Mean SD t-test P
Observer 64.14 12.23 62.61 10.64 0.60 NS
Note. Dx = Diagnosis. Two-tail t-test of mean differences considered Non Significant 
(NS) if the probability is greater than 0.05.
The following is a summary of the results:
1. CAADID and the CAARS are in good agreement on ADHD Hyperactive/ 
Impulsivity subtype for the CAARS Self-Report, Screening-Report (doctor), and 
Observer-Report.
2. CAADID and CAARS are in good agreement for Combined Subtype for the 
CAARS Self-Report and Screener (doctor), but not for the Observer report.
These results demonstrate two main conclusions. First, on the whole, the CAARS 
symptom measures of the D5Af-/FHyperactive/Impulsivity subtype are in substantial 
agreement: whether reported by self, an observer, or the investigator using the screening 
version. Mean scores of pathology ratings on the CAARS are significantly higher for the 
group diagnosed by the CAADID compared to the group not diagnosed with 
Hyperactive/Impulsivity subtype.
Second, the CAADID diagnostic tool duplicates results from the CAARS 
symptom measures for the Combined Subtype with one exception: ratings by the
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observer. These results point to the desirability of a full diagnostic workup when only 
ratings from an observer are available.
Effect size (ES) is a measure of how large an effect is when expressed in standard 
deviation units (Cohen, 1988). This allows comparison of experimental effects with 
varying sample sizes or different units of measurement. ES may be calculated in several 
different ways, but is calculated here by Cohen’s (1988) method, from the difference 
between the means of the experimental and control samples, divided by the pooled 
standard deviation: Mean 1- Mean 2/ Upooied. Cohen (1988) considered ES of 0.2 or less 
to be “small”; 0.5 or less to be “medium”; and 0.8 or larger to be “large.” The ESes in 
this study for Tables 3-8 were 0.957, 1.098, 0.606, 0.632, 0.742, and 0.133.
Thus, all of the ESes are large or medium with the exception of the Observer’s 
ratings of the Combined Subtype, which is in the “small” range. The rather large ES for 
both Self and Screening Doctor rating of Hyperactivity/Impulsivity (H/I) implies that a 
trained professional and his or her patient will be in close agreement regarding diagnosis 
of H/I. However, the Observer’s ratings are not likely to be reliable in picking out the 
Combined subtype diagnosis, which involves recognizing both H/I and Inattention.
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CHAPTER V
IMPLICATIONS OF FINDINGS, CONCLUSIONS,
AND RECOMMENDATIONS
Introduction
This chapter summarizes this study’s intent, as well as the findings and 
implications for further research. The summary of the study’s intent consists of the 
study’s problem, purpose, and methodology.
Problem
Currently there are several limiting factors regarding measures used to diagnose 
and assess adult ADHD. Most ADHD research studies have been child based, resulting 
in a limited understanding of the manifestation and diagnostic issues surrounding adults. 
Furthermore, current or newly developed adult tests lack psychometric analysis, 
incorporation of the DSM-IV, and use in major research studies that confirm validity and 
reliability.
Purpose
The purpose of this study was to compare the results from two different adult 
ADHD tools: the CAARS, a normed instrument for assessing symptoms of ADHD; and 
the CAADID, a diagnostic interview covering the formal criteria for diagnosis of ADHD.
84
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L ite ra tu re  R eview
Attention Deficit Hyperactivity Disorder is considered one of the most commonly 
diagnosed psychiatric disorders of children and adolescence (Dulcan & Benson, 1997). It 
is also believed that 1% to 2% of all adults have ADHD (Shekim et al., 1990). Adults 
and children manifest symptoms of ADHD very differently. ADHD typically refers to a 
developmental disorder of childhood characterized by persistent patterns of inattention 
and/or hyperactivity-impulsivity. It is also not enough to say that the symptoms are 
present, hut there must also be evidence of a marked interference in the person’s social, 
academic, or occupational functioning. These “impairments” should not be better 
explained by other disorders, such as Pervasive Developmental Disorders, Schizophrenia, 
or any other Psychotic condition (American Psychiatric Association, 1994).
ADHD is a chronic, lifetime disorder that takes a considerable toll on those 
suffering from it as well as the families and communities who care for these individuals. 
Significant proportions of those with ADHD end up with serious social, emotional, 
interpersonal, and economic limitations.
Currently no single cause of ADHD has been discovered. However, it is known 
that ADHD has strong genetic temperamental, neuropsychological, social, and 
environmental risk factors. Fetal alcohol syndrome, perinatal traumas, narcotics, poverty, 
abuse, psychosocial trauma, or parental psychopathology are other risk factors of ADHD. 
When clinicians make a diagnosis of a patient they usually follow the standards set by the 
most current edition of the Diagnostic and Statistical Manual o f Mental Disorders-IV 
{DSM-IV) (APA, 1994). These standards are outlined as follows:
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A. Either (1) or (2)
(1) six (or more) of the following symptoms of inattention have persisted 
for at least 6 months to a degree that is maladaptive and inconsistent with 
developmental level:
Inattention
(a) often fails to give close attention to details or makes careless 
mistakes in schoolwork, work, or other activities
(b) often has difficulty sustaining attention in tasks or play 
activities
(c) often does not seem to listen when spoken to directly
(d) often does not follow through on instructions and fails to finish 
schoolwork, chores, or duties in the workplace (not due to oppositional 
behavior or failure to understand instructions)
(e) often has difficulty organizing tasks and activities
(f) often avoids, dislikes, or is reluctant to engage in tasks that 
require sustained mental effort (such as schoolwork or homework)
(g) often loses things necessary for tasks or activities (e.g., toys, 
school assignments, pencils, books, or tools)
(h) is often easily distracted by extraneous stimuli
(i) is often forgetful in daily activities
(2) six (or more) of the following symptoms of hyperactivity-impulsivity 
have persisted for at least 6 months to a degree that is maladaptive and 
inconsistent with developmental level:
Hyperactivity
(a) often fidgets with hands or feet or squirms in seat
(b) often leaves seat in classroom or in other situations in which 
remaining seated is expected
(c) often runs about or climbs excessively in situations in which it 
is inappropriate (in adolescents or adults, may be limited to subjective 
feelings of restlessness)
(d) often has difficulty playing or engaging in leisure activities
quietly
(e) is often “on the go” or often acts as if “driven by a motor”
(f) often talks excessively 
Impulsivity
(g) often blurts out answers before questions have been completed
(h) often had difficulty awaiting turn
(i) often interrupts or intruded on others (e.g., butts into 
conversations or games)
B. Some hyperactive-impulsive or inattentive symptoms that caused impairment 
were present before age 7 years
C. Some impairment from the symptoms is present in two or more settings (e.g., 
at school or work) and at home)
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D. There must be clear evidence of clinically significant impairment in social, 
academic, or occupational functioning
E. The symptoms do not occur exclusively during the course of a Pervasive 
Developmental Disorder, Schizophrenia, or other psychotic Disorder and are not 
better accounted for by another mental disorder (e.g.. Mood Disorder, Anxiety 
Disorder, Dissociative Disorder, or a Personality Disorder) (APA, 1994, pp. 84- 
85)
In October o f 1997 The American Academy of Child and Adolescent Psychiatry 
(AACAP) published their standard of care for adults who have or may have ADHD 
(Dulcan & Benson, 1997).
The outline that follows is the standard of care recommended by AACAP:
I. Initial evaluation (a complete psychiatric assessment is indicated; see American 
Psychiatric Association Work Group on Psychiatric Evaluation of Adults [1995]).
A. Interview with patient.
1. Developmental history.
2. Present and past DSM-IV symptoms of ADHD (may use 
symptoms or criterion checklist or self-report form).
3. History of development and context of symptoms and resulting 
past and present impairment.
a. School (learning, academic productivity, and behavior).
b. Work.
c. Family.
d. Peers.
4. History of other psychiatric disorders.
5. History of psychiatric treatment.
6. DSM-IV symptoms of possible alternate or comorbid 
psychiatric diagnoses, especially:
a. Personality disorder.
b. Mood disorders -depression or mania.
c. Anxiety disorders.
d. Dissociative disorder.
e. Tic disorder (including Tourette’s disorder).
f. Substance use disorder.
g. Learning disorders.
7. Strengths (e.g., talents and abilities).
8. Mental status examination.
B. Standardized rating scales completed by the patient’s parents.
C. Medical History.
1. Medical or neurological primary diagnosis (e.g., thyroid 
disease, seizure disorder, migraine, head trauma).
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2. Medications that could be causing symptoms (e.g., 
phénobarbital, antihistamines, theophylline, sympathomimetics, steroids).
D. Family history.
1. Developmental and learning disorders.
2. Family coping style, level of organization, and resources.
3. Family stressors.
4. Abuse or neglect (as victim or perpetrator).
E. Interview with significant other or parent, if available.
F. Physical evaluation.
1. Examination within 12 months or more recently if clinical 
condition has changed.
2. Further medical or neurological evaluation as indicated.
G. School information.
1. Standardized rating scales if completed during childhood.
2. Narrative childhood reports regarding learning, academic 
productivity, and behavior.
3. Reports of testing (e.g., standardized group achievement tests 
and individual evaluations).
4. Grades and attendance records.
H. Referral for additional evaluations if indicated.
1. Psychoeducational evaluation.
2. IQ.
3. Academic achievement.
4. Learning disorders evaluation.
5. Neuropsychological testing.
6. Vocational evaluation.
II. Treatment planning.
A. Establish target symptoms of ADHD and baseline levels of 
impairment.
B. Consider treatment for comorbid conditions (monitor possible drug- 
seeking behavior).
C. Prioritize modalities to fit target symptoms and available resources.
D. Monitor multiple domains of functioning.
1. Academic or vocational.
2. Daily living skills.
3. Emotional adjustment.
4. Family interactions.
5. Social relationships.
6. Medication response.
E. Periodically reevaluate the efficacy of and need for additional 
interventions.
F. Maintain long-term supportive contact with the patient and family to 
ensure compliance with treatment and to address new problems that arise.
III. Treatment.
A. Education for patient, spouse, or other significant persons.
B. Consideration of vocational, counseling, or training.
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C. Medication.
1. Stimulants.
2. Tricyclic antidepressants.
3. Other antidepressants.
4. Other drugs (buspirone, propranolol).
D. Psychosocial interventions. Individual cognitive therapy; “coaching.”
E. Family psychotherapy if family dysfunction is present.
F. Referral to support group, such as CHADD.
G. Other treatments are outside the realm of the usual practice of 
psychiatry (The American Academy of Child and Adolescent Psychiatry (Dulcan 
& Benson, 1997, pp. 111-112).
The American Academy of Child and Adolescent Psychiatry (AACAP) also 
recommends that a complete psychiatric evaluation be completed, with particular 
attention to the core symptoms of ADHD. This evaluation should determine if symptoms 
were present before the age of 7 years. A childhood history is considered essential in 
making a diagnosis in an adult. Medical history and a recent physical examination with 
laboratory studies are necessary in order to rule out conditions that could be mistaken for 
ADHD (Dulcan & Benson, 1997). AACAP also recommends that adult patients read 
books and newsletters about ADHD and attend support groups. There are several 
medications used to treat ADHD. Currently, methylphenidate is the most commonly 
used stimulant in the treatment of ADHD (Conners, 2002).
When Change Occurs
There are many theories o f how to create change. As with any research one hopes 
that their research will have some influence on the field they are studying. Therefore not 
only is the research in itself important, but also the theory the researcher picks to 
implement the change that his/her research may bring to the field. Selecting this theory 
also demonstrates a commitment to the process of leadership and accountability to one’s 
research.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
90
Duke University’s Executive Education program has been ranked number one the 
past 4 years (Duke Corporate Education, 2005). Duke University also bas a Leadership 
Roundtable every year that is open to leaders from various backgrounds. It is through 
this program that Duke has developed a series of leadership books on various topics. The 
hook Influencing and Collaborating for Results (Duke Corporate Education, 2005) 
details how to evolve change after an idea has been developed. The foundation to this 
theory is the importance of communication within a collaborated team, so that a 
sustainable relationship will create change for this project as well as for others in the 
future.
This theory was chosen because it applied best to the initial conception of this 
research. The first stage of the Duke theory is collaboration and the second is influence.
Both of these components where applied for this research in the following ways:
1. Collaboration: This research is a collaborative effort with the following 
universities: Children’s Hospital in Montreal, University of Toronto, the University of 
British Columbia, Yale University, and Duke University. This research not only took 
into account the universities but also the people who would be a part of the team: Keith 
Conners, Thomas Brown, Lily Hechtman, Umesh Jain, Diane Johnson, Donald Quinlan, 
and Margaret D. Weiss. All of these researchers are well-known experts in the field of 
ADHD. Each team member is committed to making this research process be productive 
through his/her commitment of adopting and following standard codes of ethics in 
research protocols.
One of the key factors of the Duke change theory is that the team continues to 
work together on future projects because of the collaboration efforts they put forth in
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current and past research projects. Many of these researchers have worked together in 
the past and have spent years developing among them the credibility principles of 
keeping good company, building goodwill, keeping engaged, and making connections. 
The team also continues to work together on this project and others because of the respect 
they have established for each other through their collaborative work.
2. Influence: This collaborative team is now working on the final aspect of this 
research through writing up this research for journal article submissions. The team is still 
using the collaborative approach at this stage. The team is committed to presenting 
papers to various professional conferences.
Every scientific study or idea has the potential for being an agent of change in the 
way individual patients are eventually understood and treated. Ultimately, scientific 
study of any disorder, such as adult ADHD in this study, must exert its effects through 
individual practitioners. In this study, I have tried to show that a certain approach to 
diagnosis, the use of a comprehensive interview, has validity for diagnosing ADHD. It is 
my expectation that data from the study will prompt some practitioners to use these tools. 
If data continue to confirm the value of these tools and result in a wider acceptance, then 
I may expect initial changes in the form of compliance to result in a period of more 
complete identification with the approach.
How does one know that research has initiated change? In psychology/ 
psychiatry, change usually is evident in the recommendations of prestigious academic 
bodies such as NIMH, APA, ACAP, FDA, etc. Another way change can be assessed is 
by the number of scientific articles on similar topics that have been published. As one 
change theory suggests (Day, 2001), the motion of change can occur the moment the idea
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is conceived. Only time will shadow how far-reaching the outer circumference of change 
will extend to creating change in diagnosing of adult ADHD.
M ethodology
The overall study, from which this study was extracted, was sponsored by an 
educational grant from Smith-Kline Beecham, entitled Treatment o f  Adults With 
Attention Deficit Hyperactivity Disorder and Varying Degrees o f Anxiety and Depressive 
Symptoms. Ninety-eight patients, between the ages of 18 and 60 years, were recruited for 
the study. Data from the CAARS and CAADID were collected from the patients, 
observer, and physicians. The present study utilizes data only from the baseline visit.
The CAARS comes in several different versions. I used the following versions: 
Conners’ Adult ADHD Rating Scales Self-Report: Long Version (filled out by the 
patient); Conners’ Adult ADHD Rating Scales Observer-Report: Screening Version 
(filled out by the physician); and Conners’ Adult ADHD Rating Scales Observer-Report: 
Long Version (filled out by a spouse, friend, or significant other).
All versions of the CAARS mentioned above include the symptomatic criteria for 
ADHD according to the DSM-IV. The long versions of the self and observer report are 
identical except for pronoun differences according to the person being rated. The 
Screening Version includes only the DSM-IV symptoms and a composite index. Thus, it 
is possible to compare across the CAARS instruments with respect to their assessment of 
DSM-IV symptoms.
Unlike these rating scales, the CAADID is an interview that not only contains the 
basic symptoms of ADHD, but also the other diagnostic criteria, including age of onset, 
chronicity, pervasiveness of symptoms, impairments across multiple domains, and most
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importantly, the verification of childhood onset of the disorder. The study examined 
whether the complete diagnostic interview is capable of agreeing with the DSM-IV 
subtyping arrived at independently from the symptom rating scales.
Patients were diagnosed as having either a subtype of ADHD or not having a 
subtype by the CAADID. Qualitative methods were used, via the CAADID, in which a 
series o f questions was asked and clinical judgment made for separating the sample into 
two groups: those with a CAADID diagnosis of Combined or Hyperactive/Inattentive 
subtype and those without a CAADID diagnosis of Combined or Hyperactive/Inattentive 
subtype. The CAARS rating scales are quantitative, that is, the scores for individual 
groups of items are summed and the totals transformed into standard scores.
Data Analysis
After the sample was divided into two groups, the difference between the 
diagnosed group and non-diagnosed group on each of the CAARS Rating Scales was 
examined by independent sample f-test. An independent t-test is when the groups are 
composed of different individuals (i.e., not repeated measures on the same individuals, or 
when the groups are correlated by virtue of some common factor). The difference is 
expressed as a probability. For this study probability is considered significant when it is 
less then 0.05. This means that if this experiment were repeated 100 times, the results 
would occur by chance less than 5 times.
The r-test used in this study is a two-tail test. Since a normal distribution (bell 
curve) has two tails, the t-test can be calculated for one direction only, or for both 
directions (i.e., for both high and low score outcomes). A two-tail test was used in this 
study versus a one-tail test because it was theoretically possible that either group could
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have higher or lower scores than the other group, so a two-tail test was thought to be 
appropriate.
Findings
The null hypotheses for questions 1-5 were rejected while the null hypothesis for 
question 6 was accepted. In summary, the ratings by the CAARS are not considered a 
satisfactory method for a diagnosis when information only from an outside observer is 
available. When information is gathered by the mental health professional or the patient, 
diagnoses will closely approximate the more comprehensive diagnostic instrument 
(CAADID).
Research Questions and Null Hypotheses
Research Question 1. Is there a difference in the mean score on the CAARS as 
rated by the patient between those patients who have been diagnosed, according to the 
CAADID, as Hyperactive/Impulsive subtype of ADHD compared to those who have not?
Null Hypotheses 1. There will be no difference between the mean CAARS 
ratings by the patient for Hyperactive/Impulsive symptoms for groups diagnosed by the 
CAADID as ADHD Hyperactive/Impulsive subtype versus those not diagnosed with 
ADHD Hyperactive/Inattentive subtype.
The data compare the mean scores of the two diagnostic groups using the CAARS 
self-report of symptoms from the patient. The data indicate that the mean score of the 
Hyperactive/Impulsive subtype is significantly higher than the mean score of the non- 
Hyperactive/Impulsive group. The significantly higher mean (average) score indicates 
that the Hyperactive/Impulsive patients rate themselves higher (have more symptoms)
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than the other group. The two groups have a mean difference in scores that would occur 
by chance less than one time in ten thousand. Therefore the null hypothesis that the two 
means would not differ was rejected.
Research Question 2. Is there a difference in the mean score on the CAARS as 
rated by the doctor between those patients who have been diagnosed, according to the 
CAADID, as Hyperactive/Impulsive subtype of ADHD compared to those who have not?
Null Hypothesis 2. There will be no difference between the mean CAARS ratings 
by the doctor of ADHD Hyperactive/Impulsive symptoms for groups diagnosed by the 
CAADID as ADHD Hyperactive/hnpulsive subtype versus those not diagnosed with 
ADHD Hyperactive/Impulsive subtype.
The data compare the mean scores of the two diagnostic groups using the CAARS 
screening report of symptoms. The data indicate that the mean score of the Hyperactive/ 
Impulsive subtype is significantly higher than the mean score of the non-Hyperactive/ 
Impulsive group. The significantly higher mean (average) score indicates that the 
Hyperactive/Impulsive patients had more symptoms than the other group. The two 
groups have a mean difference in scores that would occur by chance less than one time in 
ten thousand. Therefore the null hypothesis that the two means are the same was 
rejected.
Research Question 3. Is there a difference in the mean score on the CAARS as 
rated by the observer (significant other) between those patients who have been diagnosed, 
according to the CAADID, as Hyperactive/Impulsive subtype of ADHD compared to 
those who have not?
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Null Hypothesis 3. There will be no difference between the mean CAARS ratings 
by the observer for Hyperactive/Impulsive symptoms for groups diagnosed by the 
CAADID as ADHD Hyperactive/Impulsive subtype versus those not diagnosed with 
ADHD Hyperactive/Impulsive subtype.
The data indicate that the mean scores of the Hyperactive/Impulsive subtype are 
significantly higher than the mean score of the non-Hyperactive/Impulsive group. The 
significantly higher mean (average) score indicates that the Hyperactive/Impulsive 
patients had more symptoms than the other group. The two groups have a mean 
difference in scores that would occur by chance less than eight times in a thousand. 
Therefore the null hypothesis that the two means would not differ was rejected.
Research Question 4: Is there a difference in the mean score on the CAARS as 
rated by the patient between those patients who have been diagnosed, according to the 
CAADID, as Combined subtype of ADHD compared to those who have not?
Null Hypothesis 4. There will be no difference between the mean CAARS ratings 
of the ADHD Combined subtype by the patient for groups diagnosed by the CAADID as 
ADHD Combined subtype and not diagnosed with ADHD Combined subtype.
The data indicate that the mean scores o f the Combined subtype are significantly 
higher than the mean score of the non-Combined subtype group. The significantly higher 
mean (average) score indicates that the Combined subtype patients rate themselves higher 
(have more symptoms) than the other group. The two groups have a mean difference in 
scores that would occur by chance less than three times in a thousand. Therefore the null 
hypothesis that the two means would not differ was rejected.
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Research Question 5. Is there a difference in the mean score on the CAARS as 
rated by the doctor between those patients who have been diagnosed, according to the 
CAADID, as Combined subtype of ADHD compared to those who have not?
Null Hypothesis 5. There will be no difference between the mean CAARS ratings 
of the ADHD Combined subtype by the doctor for groups diagnosed by the CAADID as 
ADHD Combined subtype and not diagnosed with ADHD Combined subtype.
The data indicate that the mean scores of the Combined subtype are significantly 
higher than the mean scores of the non-Combined subtype group. The significantly 
higher mean (average) score indicates that the Combined subtype patients had more 
symptoms than the other group. The two groups have a mean difference in scores that 
would occur by chance less than one time in a thousand. Therefore the null hypothesis 
that the two means would not differ was rejected.
Research Question 6. Is there a difference in the mean score on the CAARS as 
rated by the observer between those patients who have been diagnosed, according to the 
CAADID, as Combined subtype of ADHD compared to those who have not?
Null Hypothesis 6. There will be no difference between the mean CAARS ratings 
of the ADHD Combined subtype by the observer for groups diagnosed by the CAADID 
as ADHD Combined subtype and not diagnosed with ADHD Combined subtype.
The data indicate that the mean scores of the Combined subtype are not 
significantly higher than the mean scores of the non-Combined subtype group. The non- 
significantly higher mean (average) score indicates that the Combined subtype patients 
did not have more symptoms than the Non-Combined subtypes. The two groups have a 
mean difference in scores that is well below the critical value for the t-test, and is
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therefore non-significant. Therefore the null hypothesis that the two means would not 
differ was accepted.
While Self-Report and Screener-Report (doctor) of symptoms are in substantial 
agreement when it comes to a diagnosis of ADHD Combined subtype by the CAADID, 
the observer did not distinguish between CAADID diagnosed and not-diagnosed groups. 
A diagnosis is more than symptoms, so when the information from the CAADID is 
added, a more accurate diagnosis of the symptoms can be made.
Summary
The following is a brief summary of the interpretation of the data.
1. CAADID and the CAARS are in good agreement on ADHD Hyperactive/ 
Impulsivity subtype for the CAARS Self-Report, Screening-Report (doctor), and 
Observer-Report. Hyperactive/Impulsivity behavior is readily recognized by all rating 
sources because the behaviors are easy to see and describe.
2. CAADID and CAARS are in good agreement for Combined Subtype for the 
CAARS Self-Report and Screener (doctor), but not for the Observer report.
Discussion of Findings
This study is important because it shows that the rating scales have sufficient 
validity for medication management. Previous studies demonstrate that 76% of adults 
with ADHD will respond to treatment with stimulant medication, when treated with 
adequate doses (Spencer et al., 1995; Wilens et al., 1995). One way to assure that 
treatment is adequate is by measuring the symptoms on scales before and after treatment.
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ADHD is a complex disorder with many comorbid conditions in addition to the 
core symptoms. Identification of these core symptoms is therefore a challenging clinical 
issue. Biederman et al. (1993) studied 84 adults referred with and without ADHD. 
Seventy-seven percent of the adults referred for ADHD met the criteria for comorbidity. 
This study is important in showing that doctors can use valid and reliable measures of 
adult ADHD, despite the comorbidity. This should enhance their ability to develop 
appropriate management and follow-up of the pharmacologic and other treatments.
Correctly identifying symptoms of ADHD has an effect on treatment and 
diagnosis of ADHD, and one can see the trickle-down effect this would have on society 
in general. If patients are diagnosed and treated correctly, many of the problems 
communities face in dealing with this disorder would be eliminated. Statistically, adults 
with ADHD are at a higher risk for losing their jobs, families, and friendships. They also 
have a higher likelihood of abusing drugs and alcohol. The disorder can result in 
problems with mood swings, depression, poor self-esteem, and never reaching one’s full 
potential as an adult (Hechtman & Weiss, 1986). The impact therefore is not only 
immense for communities but also for patients to become the potential leaders they aspire 
to be in their field of study.
Effect size (ES) is a measure of how large an effect is when expressed in standard 
deviation units (Cohen, 1988). This allows comparison of experimental effects with 
varying sample sizes or different units of measurement. ES may be calculated in several 
different ways, but is calculated here by Cohen’s (1988) method, from the difference 
between the means of the experimental and control samples, divided by the pooled 
standard deviation: Mean 1- Mean 2/ Upooied. Cohen (1988) considered ESes of 0.2 or less
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to be “small”; 0.5 or less to be “medium”; and 0.8 or larger to be “large.” The ESes in 
this study for Tables 3-8 were 0.957, 1.098, 0.606, 0.632, 0.742, and 0.133.
Thus, all of the ESes are large or medium with the exception of the Observer’s 
ratings of the Combined Subtype, which is in the “small” range. The rather large ES for 
both Self and Screening Doctor rating of Elyperactivity/Impulsivity (H/I) implies that a 
trained professional and his or her patient will be in close agreement regarding diagnosis 
of H/I. However, the Observer’s ratings are not likely to be reliable in picking out the 
Combined subtype diagnosis, which involves recognizing both H/I and Inattention.
Several hypotheses may explain why the observer ratings were less valid 
diagnostically than self-report and doctors’ ratings. Patients selected their own observer. 
Data on who the patients selected as their observer were not available. Knowing this 
information and detailed information on the relationship between the observer and patient 
would have been beneficial. Such things as how long they have known each other, how 
fi-equently they see each other during the day, etc., might account for the lesser accuracy 
of observers. Also observers may be better at identifying hyperactive than inattention 
behavior compared with doctors and patients.
Self-report o f the patient and the doctor’s screening report agree closely with the 
CAADID diagnoses. The results indicate that these rating scales can be used as a valid 
indicator of a comprehensive diagnosis derived from an extensive interview. These 
scales work because of the patient’s firsthand knowledge of their disability and because 
the doctors were highly trained.
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C onclu sion
The most important conclusion of the study is that the ratings by the CAARS are 
a satisfactory method for diagnosing ADHD when information is used directly from the 
patient and doctor, but not from an outside observer alone. When information is gathered 
from the mental health professional or the patient, diagnoses will closely approximate a 
more comprehensive interview diagnostic instrument (CAADID). Self-Report and 
Screener-Report (doctor) are in substantial agreement with the CAADID when it comes 
to a diagnosis of ADHD Hyperactivity/Impulsivity and Combined subtypes. But the 
observer (significant other) did not distinguish between CAADID diagnosed and non­
diagnosed individuals.
Initial diagnosis of ADHD information can come from several different 
perspectives: for example, a physician, research assistant/nurse, friend, a significant 
other, or from the patient themselves. This study shows that in most cases these different 
perspectives reveal the same picture of the patient, but there are instances where these 
sources paint a different picture. The data reveal that a childhood history and an 
extensive interview are needed to supplement observation and ratings by an observer 
when diagnoses are made.
As outlined by the American Academy of Child and Adolescent Psychiatry 
(Dulcan & Benson, 1997), before a diagnosis of ADHD is made by a clinician he/she 
needs to complete several steps. Two of these steps are obtaining a detailed record of the 
patient’s symptoms and acquiring both a childhood and adult history (medical, education, 
home life, work experience, etc.) from the patient. The current study has been very 
important in giving mental health professionals valid and reliable measures to use in 
making a diagnosis using the prescribed professional guidelines from AACAP.
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Recommendations for Further Study
The following is a list of recommendations for further study:
1. Follow-up studies of ADHD in adulthood show there may be different 
outcomes. Some patients become successful leaders, advance in education, and assume 
jobs with numerous responsibilities, whereas other patients are not successful. These 
tools that have been validated could be useful in determining which ADHD adults are 
likely to be successful. For example, one subtype or another may have differential 
impact on the outcome of the patient’s leadership skills.
2. Cross Validation of results should be studied before the findings are translated 
into clinical practice. Cross validation means a replication of the study on a new sample 
of adult ADHD participants.
3. Further study should be conducted of patient characteristics (social class, 
gender, age, education, etc.) that might bias diagnostic information.
4. Further research is needed to determine what characteristics make a reliable 
observer or unreliable observer.
5. If symptoms were changed to better describe adult hyperactivity, there might be 
a better agreement in diagnosing combined type and the Hyperactive Type of ADHD in 
adults.
6. If symptoms were changed to better describe adult inattentive symptoms, there 
might be a better agreement in diagnosing Inattentive Type of ADHD in adults.
7. Further study is required of the impact o f results in patients who do not have 
the comorbidity of Anxiety Disorder.
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IRBNo. 2265-00-12R1 
Consent for Research; Treatment of Adults with Attention Deficit Hyperactivity Disorder 
and Varying Degrees of Anxiety and Depressive Symptoms
IRB No. 2265-00-12R1 
CONSENT FOR RESEARCH
Treatment of Adults with Attention Deficit Hyperactivity Disorder and Varying Degrees 
of Anxiety and Depressive Symptoms
SmithKline Beecham 
Protocol 707
Principal Investigator: Diane E. Johnson, Ph.D.
Attention Deficit Disorder Program 
Duke University Medical Center 
Box 3431
Durham, NC 27710 
(919)416-2082
INTRODUCTION:
You are being asked to participate in a medical research study. Before you decide to participate, you 
should read this form. This form, called a consent form, explains the study. Please ask as many questions 
as needed so that you can decide whether or not you want to be in the study. This consent form may 
contain words that you do not understand. Please ask your study doctor or the study staff to explain any 
words or information that you do not understand. To be in this study, you cannot already be in another 
medical research study.
RATIONALE OF ADHD:
Attention Deficit Hyperactivity Disorder (ADHD) begins in early childhood and is 
defined as severe inattention and/or hyperactivity and impulsivity that impairs the child’s 
ability to function successfully at home, school, or socially. Not all children outgrow 
ADHD. ADHD is found in 1% to 9% of the adult population and results in continued 
difficulties at work, in relationships, and in functioning at home. More than half of adults 
with ADHD also experience depressed mood and/or anxiety.
There have been very few research studies o f medications for adults with ADHD. The purpose of this 
study is to see how effective two different medications are (either taken alone or together) in reducing 
ADHD symptoms and improving one’s functioning in life.
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STUDY MEDICATION:
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The two medications in this study have been approved by the Food and Drug 
Administration and are available to anyone when prescribed by a doctor. One drug is 
called Paxil (paroxetine HCl) which is a medication taken once a day to treat depression 
and/or anxiety. The other drug is called Dexedrine (dextroamphetamine sulfate) which is 
taken one or more times a day for the treatment o f ADHD.
PROCEDURES:
This research study will enroll 100 adults with ADHD at five different research sites 
across the United States and Canada. At this site, 20 adults with ADHD will participate. 
The study consists of up to 11 visits over 20 weeks of treatment. Today’s visit is the first 
of two screening appointments where we will determine if you do have ADHD and if this 
study is a good idea for you to consider. If you decide to participate and you qualify, you 
will begin medication at the end of the second screening visit. Then, there are four 
“titration (dosing)’’ visits over four weeks where we will evaluate how you are doing on 
medication and will change the medication dose up or down until the ADHD symptoms 
have gone away. There must be an improvement in ADHD symptoms at the end of this 
four-week dosing period in order to continue. Once we determine the best medication 
dose for you, you will continue taking that dose o f medication for the rest of the study. 
You will come in five more times, at weeks 6, 8, 10, 15, and 20, the final study visit. It is 
important for you to know that you will have to ask someone (such as a wife or husband, 
roommate, adult child, parent, employer) who currently knows you and your habits well, 
to complete several checklists/rating scales about you during your participation in this 
study. This should be the same person throughout the 20 weeks of this study. This 
person can turn in forms to you or us and does not have to come to the clinic visits.
.Screening Visit:
Today’s visit will last three to four hours. The second screening visit may last two to three hours. You will 
have psychological tests/interviews and a physical to help the study doctor determine if  you meet the 
requirements to be in the study. These are called “screening” tests. The screening tests for this study are:
Psychological Screening:
Psychsocial history, computerized version 
Stractured Clinical Interview for DSM IV, Axis I
Conners’ Adult Attention Deficit Rating Scales -  completed by you, your rater, and the 
clinician
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Psychological Screening (continued):
Adult Symptom Inventory, completed by yourself and the other person
LIFE measure o f functioning
Global Assessment of Functioning
Brown Attention Deficit Disorder Rating Scale
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Conners Adult ADHD Diagnostic Interview for DSM-IV (Part I: History and Part II: 
Diagnostic Interview)
Sheehan Disability Scale 
Social Adjustment Scale
Weschler Adult Intelligence Scale, 3'“* Edition -  three subtests 
Weschler Memory Scale, 3'^ '’ Edition -  one subscale 
Medical Screening:
Medical history 
Physical exam 
Vital signs taken 
Side Effect Report
Hamilton Rating Scale for Depression 
Hamilton Rating Scale for Anxiety
Blood pregnancy test -  for women o f child-bearing potential 
Urine drug screen -  if required
Women o f child-bearing potential, who are not pregnant, will be allowed in the study. It is important that 
you understand that Paxil and Dexedrine are both medications that have warnings about pregnant women 
taking them. This research study may have an adverse reaction on an unborn child and should therefore not 
be done during pregnancy. It will be necessary that a pregnancy test (using 2 teaspoons o f  blood drawn 
from a vein by a needle stick) be done first. By signing this consent form, you are telling us that you are 
not pregnant at this time.
For women of child-bearing potential, if  you are sexually active, it is also important that you are currently 
taking appropriate contraceptive measures now and will continue for the duration o f the study. Acceptable 
birth control methods include hormonal contraception (such as birth control pills or Depo-Provera), barrier 
methods used with spermicides, or contraceptive devices. By signing this form, you are indicating that you 
will take contraceptive measures for the duration of this study.
To be included in the study, you must be between the ages o f 18 and 60 years old and have ADHD 
currently as determined by the psychological screening tests. You will not be allowed to participate in the 
study if  you are currently abusing alcohol or illegal dmgs,
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If you have an eating disorder (such as anorexia or bulimia), any brain or nerve-related 
diseases, if you are taking any other medications for psychiatric reasons, if you are 
having thoughts of hurting yourself, if you do not understand the English language well 
enough to understand what needs to be done in the study, or if you know now that you 
can not do the study for the next five months.
You will receive the study medication at the end o f the second screening visit. There are four different 
groups and you have an equal chance o f being assigned to any o f the four groups. Three o f  the groups are 
active medication -  either Paxil, Dexedrine, or both Paxil and Dexedrine. The fourth group is a placebo 
(non-active, “sugar pill”) medication. This means that you have a 3 in 4 or 75% chance o f being on an 
active medication and a 1 in 4 or 25% chance o f  not receiving any active medication throughout the study. 
You will not know which medication group you are in. In addition, all patients will be on placebo for one 
week during the study. The study doctor who is dispensing the medication will not know what medication 
you are taking. The person who is evaluating how you are doing and gathering the information about how 
you are responding to the medication will not know what medication group you are in.
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All medication groups require you to take four capsules of medication a day, by mouth, two every morning 
and two at midday, every day o f the week. All medications will look the same. The four medication 
groups are as follows:
Paxil: You will begin by taking a 10 mg Paxil capsule and a placebo capsule by mouth in 
the morning and two placebo capsules at lunch. We may increase the dosage during the 
“titration (dosing)” visits by 10 mg intervals to a maximum of 40 mg by mouth every 
morning and a placebo capsule at lunch.
Dexedrine; You will begin by taking a 5 mg Dexedrine capsule and a placebo capsule by mouth in the 
morning and a 5 mg Dexedrine capsule and a placebo capsule at lunch. We may increase the dosage during 
the “titration (dosing)” visits by 10 mg/intervals to a maximum of 20 mg by mouth every morning and 20 
mg by mouth at lunch.
Combination: You will begin by taking two capsules in the morning, by mouth, one contains Paxil 10 mg 
and the other contains Dexedrine 5 mg, and you will take a Dexedrine 5 mg capsule and a placebo capsule 
at lunch. We may increase the dosage of Paxil and/or Dexedrine using the dosing described for each 
medication separately to a maximum of Paxil 40 mg and Dexedrine 20 mg by mouth every morning and 
Dexedrine 20 mg by mouth at lunch.
Placebo: You will take two placebo capsules by mouth in the morning and two placebo capsules by mouth 
at lunch.
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You will be expected to return any unused study medication at each visit. The other 
person’s rating scale will also have to be returned at each visit.
Regardless o f  the medication group to which you are assigned, you will also receive Problem-Focused 
Therapy for ADHD which provides support, education, and management information for major life 
problems in hopes o f helping you cope with ADHD and, if  applicable, depression and/or anxiety. The 
Problem-Focused therapy sessions will take place during each of the scheduled visits and will be done with 
the study doctor who is also giving the medication.
Four Titration fDosinel Visits (Weeks # 1. 2. 3. and 4):
On these 90 minute long clinic visits, the study doctor will rate your ADHD, mood, and anxiety symptoms, 
check your blood pressure, heart rate and weight, and ask about any side effects. You and the other person 
who is providing ratings will each complete an ADHD rating scale. Your study medication will be 
adjusted as needed. If it is determined that the ADHD symptoms have decreased and you are doing well 
before the end o f the Titration (Dosing) Visits, you may move to the Treatment Visits sooner. If you have 
not benefited from the medication given you by the end o f the Titration (Dosing) Visits, you must stop the 
study. We will work with you to find a referral, if  necessary. You will be receiving Problem-Focused 
therapy at these visits as well.
Four Treatment Visits /Weeks 6. 8. 10. and 151:
The treatment visits at Week 6 and 8 will last about 90 minutes each, and the visits at Weeks 10 and 15 
visit may last up to three hours. You will continue to receive the same medication dosage that was 
determined to be most effective for you at the Titration (Dosing) Visits for the remainder o f the study. At 
these visits, the study doctor will rate your ADHD, mood, and anxiety symptoms, check your blood
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pressure, heart rate and weight, and ask about any side effects. You and the other person who is providing 
ratings will each complete an ADHD rating scale.
Last Visit (Week 20):
At Week 20, you will discontinue medication. This visit will last up to three hours. The same procedures 
completed at the Screening Visit will occur at the end of the study. You will complete the Psychological 
and Medical Screening procedures (except that women of child-bearing potential will not have a blood 
pregnancy test). The other person’s rating scale should be returned for a final time and all unused study 
medication must be returned. At the end of your participation, whether you left the study early or 
completed the study, we will determine what treatment group you were in, and if  you were taking Paxil, 
will work with you, and your physician to slowly remove you from the medication. We will also work 
with you in finding referrals for fiirther treatment.
IRB No. 2265-00-12R1 
CONSENT FOR RESEARCH 
Treatment o f  Adults with Attention Deficit 
Hyperactivity Disorder and Varying Degrees 
of Anxiety and Depressive Symptoms
EARLY WITHDRAWAL:
If you have to discontinue the study for any reason, we ask that you come back to the clinic one last time to 
complete Last Visit procedures. It is important to know that the medication Paxil should not be stopped 
suddenly, instead, you should slowly go off the medication by having a doctor lower the dose.
RISKS AND DISCOMFORTS:
For women o f child-bearing potential, blood draws for pregnancy testing may result in pain and/or bruising 
at the place on your arm where blood is taken. Blood clots may form and infections may occur, but this 
rarely happens. If you feel faint after a blood draw, you should lie down right away to avoid falling down. 
Then you should notify one o f  the study staff.
While you are in this study you should not use any other medications (over-the-counter, herbal, 
prescription, or illegal) without approval from the study doctor. Taking other medications or dmgs could 
result in serious and even life-threatening reactions.
Paxil, the antidepressant/anti-anxiety prescription medication used in this study, is currently available to the 
general public. Reported side effects include headache (19%), weakness (13%), constipation (12%), dry 
mouth (18%), nausea (23%), dizziness (10%), and feeling tired (20%).
Dexedrine, the ADHD prescription medication used in this study, is currently available to the general 
public. Reported side effects include hypertension (high blood pressure), tachycardia (rapid heart beat). 
Central Nervous System overstimulation (jitteriness), GI disorders (stomachache), anorexia (decreased 
appetite and weight loss), and, rarely, urticaria (rash, hives, itchiness o f skin).
Pregnancy Dangers -  If you are pregnant now or think you may be pregnant, you should not enter this 
study. It is very important that you not become pregnant during this study. If you become pregnant during 
the study you will be withdrawn from the study. You are aware that not having sex is the only certain way 
to prevent pregnancy. If you are a woman who is able to become pregnant, and choose to have sex during 
this study, you agree to use a medically proven type o f birth control (discussed previously) throughout the 
study.
IRB No. 2265-00-12R1
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CONSENT FOR RESEARCH 
Treatment o f  Adults with Attention Deficit 
Hyperactivity Disorder and Varying Degrees 
of Anxiety and Depressive Symptoms
BENEFITS:
It is possible that your condition may improve, but there is no guarantee that you will receive any medical 
benefit as a result o f  being in this study. It is also possible that your condition could worsen or remain the 
same. You have a 75% chance o f being on an active medication but there is no guarantee that the active 
medication is the medication that works best for you. You will receive Problem-Focused therapy from the 
study doctor that is designed to give you support, educate you about ADHD, and teach you additional 
coping skills.
Your voluntary participation in this study may result in helping to better understand ADHD in adulthood, 
mood and anxiety symptoms that often co-occur with adult ADHD, life issues and difficulties related to 
adult ADHD, and treatment options for adult ADHD. You will receive free study medication for as long as 
you are in the study. You will also receive medical care and tests associated with this study at no cost to 
you.
COMPENSATION:
You are volunteering for this study and, therefore, will not be paid for your participation.
The sponsor, SmithKline Beecham and Duke University Medical Center make no commitment to provide 
compensation for any physical injury by the study drugs or properly performed study procedures.
ALTERNATIVE TREATMENTS:
There are several medications that are approved by the Food and Drug Administration 
(FDA) for treating the symptoms of ADHD. Both the study medications have FDA 
approval and are available to you in the community. Your alternative is to not participate 
in this study and to see your doctor for possible treatment with an approved drug for 
ADHD.
NEW FINDINGS:
If you choose to enter in this study and at a later date a more effective treatment becomes available, the 
study doctor will inform you o f the new treatment. You will also be advised of any new information that 
becomes available that may affect your willingness to remain in this study.
IRB No. 2265-00-12R1 
CONSENT FOR RESEARCH 
Treatment of Adults with Attention Deficit 
Hyperactivity Disorder and Varying Degrees 
of Anxiety and Depressive Symptoms
CONFIDENTIALITY:
Your medical records will be treated as confidential information. The sponsor (Smith-Kline Beecham) 
representative(s) and the FDA (and possibly other regulatory authorities) may review your medical record 
from this study. They may also receive copies o f  the medical records from this study. If study results are 
published, your name will not be used.
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CONTACTS/QUESTIONS:
By signing this consent form, you do not give up your legal rights.
If you have any questions about (a) this research study, (b) reporting a research-related injury or (c) 
information about study procedures, you may contact the study doctor, Diane Johnson, Ph.D. at (919)-416- 
2082 during office hours. You may also contact the study coordinator, Carolyn Cofrancesco, M.A., Ed.S. 
at (919) 416-2440 (or at (919) 970-2103 after hours). If you should become sick while you are in the study 
or experience a study-related injury, you may contact the medical director, John March, M.D., at (919) 684- 
4950 at any time.
Contacts for Research Rights - This consent and research study has been reviewed and 
approved by an Institutional Review Board (IRB). This is a group of scientific and non- 
scientific people who review research studies involving humans. The IRB follows the 
rules set forth by the U.S. Government’s Department of Health and Human Services. If 
you have questions about your rights as a study volunteer, you may contact Duke 
University Medical Center Risk Management at (919) 684-3277.
WITHDRAWAL FROM THE STUDY:
Participation in this study is completely your decision. You should have all o f  your questions answered by 
the study staff to your satisfaction before deciding to be in this study. You have the right to leave the study 
at any time. You will not be penalized, punished, or lose any benefits that you deserve if  you choose not to 
be in this study or if  you choose to leave the study at any time.
If you would like to leave the study please contact a study staff member so that you may properly leave the 
study.
IRB No. 2265-00-12R1 
CONSENT FOR RESEARCH 
Treatment o f Adults with Attention Deficit 
Hyperactivity Disorder and Varying Degrees 
of Anxiety and Depressive Symptoms
At the same time, your participation in this study may be stopped at any time without your permission by 
either the study doctor, the IRB, the sponsor, or by the FDA. You may be removed from the study if  you 
do not follow the instructions/procedures as they are given in the study or by the study staff.
In order to stay in the study, we expect you to take at least 21 out o f  28 pills a week and attend at least 7 of 
the 9 Problem-Focused therapy sessions.
If you leave the study before completing all clinic visits, you will need to return any imused study 
medication. For your safety, you will need to return to the clinic and have a physical exam and assessments 
completed.
VOLUNTEER AGREEMENT/CONSENT
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“I have read the above and have been given the opportunity to discuss it and to ask questions. These 
questions have been answered to my satisfaction. I have been informed of whom to contact to answer any 
questions I may have during the study. I understand that participation in this study is entirely voluntary and 
that I may refuse to participate or I may withdraw from the study at any time without any consequence to 
my continuing medical care. I have received a copy o f this consent form for my records. I agree to 
participate in this study”.
Signature o f Participant Date
Signature of Person Explaining Consent Date
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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c  Info
T o u r  K a m e :  
A g e : -------- S e a :  U  F
D a t e  o f  B i r t b :_____ /    /    "«tld nmi ïïSï
H o n t e  A d d brees:
T o d a y »  D a t e  / ./
For A dm inistr^îK 'e use:
C!:» » » l*'- »11 ' »
S li/IT T G  3M1 Mdi-»ki^ S»w«mEac AtiàpfMmefrutl hé» l/SAM Tmw*Wk NY
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Whaî Is going on in your life thal leads you to beliwc that you have Attention-Dcflcil/Hypeîactivily 
Disoider or ADHD?
Let's start at the bcglnirii^, Who was in your hoi
Childhood A
lîelâlioo^ liip Current Age
m l'4
HU It*
m ip^
im
(i« mf
Wliete dïd you live?
What was your father's Job?.
What wîuî yoMF mother's Job?  __ ____
Wsre you adopted?
If yea, what was your age at the time?.
*t gg iVJIJCIliSjiieiwétrriiSitiVM T«ao>.o!< mmums iw#i » «M
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Ceslatiorsa) Risk Factors
Did anyone ever you or did >w  ever hear anyone ralk atjout any of the Mowing happening 
during your mother's pregnancy with you?
Mother ai (toscemia, anemia] 
Mother look medication 
Mother smoked cigarettes 
Mother drank alcohol 
Motlrer used illicit drugs 
IPrciualure birth
Was there anything else unusual about yow mother’s  ptej 
tlf yes, pilcaae describe on die linos provided below.
T
Y
Y
Y
Y
g
Ç g o j j » e û
D elivery Risk Factors
Did any of the foJIpwlng happen at the time of your Mrth? 
Fetal distress
Ww birth weight (less than 5 lbs or 2WX) grams) 
Breech birth with forceps delivery 
Staying In the hospital longer than expected 
Anoxia flack of mg-gm, blue baJjy)
W;is there anything dse  unusual about your delivery? 
Ilf yes, please descrtbc on the lines provided below,]
T N
r
IW
N
Y »
Y
ütn
N
Y N
Y W
œ ITJ.l JLï^ lfliO*lA .tiKKM.'CiM WK&YNvjWQp IMtmiteatiÿ. v fa.-el JU-^2.^>**w«ldl W
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e m o g r a p h i c  Infor
Y o u r  N a m e ;
A g e : . Sex; M F
D ate o f  B k th ;  /  / ______ «*•dd mm yjyy
H o m e  A d d tres» !
Today’s  D a t e : _ _  /
V'Oïïïivs-iT
Ctü^Ffci A 2)MS Mwia «M J# oreeeMMl. Ia ihf V.7.A.. P<L Dm Md, K«Rlt ##)it Cinfa. )>» VixkMafjAAw.TewM*, DKMfll 1W» ivnanMsV ^
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Instruction P#ge
C<Knp)«e (hç ïccUoR for cbcJj «jiuplom by doün  ^Uic foIJowmg;
1. Ash Prinors; Çueütton. ilmt is. "Do you ollcn fa# lo pay d o st atlentson lo detail or make caideas
mistakes?' Gtk beltm-uir» rfwéip «iIuUlicxxl imd texxrei <»i i?iç JùuK pmtkded. ffjio die ermuykM
to prompt pudent ij necnxsaiy.
а, Asfc SeaawKian/ gucsWon to determine ÿ"sjpnptoin is dfrilCaKy agtnlfkunf. t /m  is, “Do yon Uilnk you have 
more probkins wSUi falling to pay atcenttoi) to detail or «taking carete^ mistake» than most people your 
age?' Mrdto note of responses on the dries pmukied.
3. Make dkUoBÎ ctedsrminaJiion qf wfurlfter potlcnt meets sj i^mplom crtteria ond ctrde Y o r  N beside 0m question 
%mpiom present On odtdWtood?"
4. y/heWter y or if  recturTcd Jot odtdt Bpmplowi preacoee. usk IVirneutf Quoslton rnodijiexljbr eWlelteoti. that Is, 
AVtren you were a rblid, did you onim fall to pay doso attention to detail or make oaretes mistakes?* («et 
itmmples ijf bc>Htt#£vs during cfiddhood and write dwm on ifie tûtes pmtrdcd, Use the esomptea to prompt 
pQtfent [fnooesisMri!.
5. AsfcSeeortdorp guoskon to tifitermifie jf Spoiploiti uaas dlnioaily atgriifumnl, thal Is, ■Wlton you were a  eldld, 
do you think that you bad mijre problems with felting to pay close attention to detail or tmiklug «vrcicss 
nUslakes than most chUdren your age?* Jtol» respomes.
б. MaJm ctinltal tktlermlination qf uihethsrpatietit meets symptom trUeriu and cüWe y  or IV beside gte 
'%ihtotom present to ehBWhtwai?'
Ibaunple:
DSM‘5V Criletefi A fi)
O fte n  fiisb. Eo pjt'ix: elfxsc: n t î e tu io i i  to  (L 'ln iK  oc  n n s k e s  co je lesF . in  s i-h û o l. xvDi'k.. n t  cA hex
nnrivjclee;
gggytaasaag^ sajja
@293%%
2%ia:
l y f l l d b  ÿ(Ai w ere b cMLûy d id^  
t o  p&y d t m  1 f i d
ents/eieampies}
EXmPlMS:
□Gardfess tMr&Wtd& in scfttwiitioffe 
OMÜ5S0C1 ÜBms/pmbleiJis knew ftpiu to do 
□Didn't go bock ooer work to check answers 
ORtistel thw^jih work wWwiif ihWting (Wi^gh
If response to Question #I itios “yes,*
Whesi you Wdf* a ehUd. 4o ymi. tWa% that 
ytrn bad ntonre pfbWtm# wiKh fidMiig to pay 
close BttciBtisB to -détail ar making careless, 
ndstakes t&an ntost c&U&en yottr agat 
fWh'te oommenls/éxnmpleàl
Sijmpîom preseitl ta aduKhcod? Symptom pr<?.wal In childhood?
^  L'»r«r«ib1n C W^ti HrMf- &WL A» fit M? PiQ. N# N*n» NY 1*130
imk1vJ.JuLi3  la cspMb. *ti» nil T'WMi*. w %i2ii jm. imii rtiw&AMiif, wi-tiwM-ai:7.
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I  cun going tu nsfc you aSmtt a variety q f beitfu/ioni that goit nutg hmie hod during yvur oduliJiood and/or 
childhood, i t  i* vcrg irnjnwtonf to mmember Iftttl mott people hope thmwi iwinniiors cturiitg the course o f 
morydofy ((A. TThat Ü am trging to delerrntne is luhethcr or not these behtudors occur or occurred /o r  you 
ntorBjheguentljif thaB/>r other people that age and/or {fyotifeet these behooiors did o r did no t cause 
pou more proNems Ihon th<® do or d id /o r other people that age.
Inattention Symptoms
DSM-IV Cf i t ùûùn  A U )
OflcLi fvikls l a  î4,ivr- c:]asc i^Ucniisjj'i l-i.i u r  nKi>:c.s ca rd < !s s  in ls lo k t  A in  sr1i<in] \vt.)rk, o r  o U ic r
chUdhoud
1. W hen you w ere a  ch ild , d id  you o ften  fall to 
pay close a tte n tio n  to  d e ta il o r  m ak e  care less  
ntistakes? fWrtie cofrunents/eusanifrfes/
rremlf mmlakea in sclioolytMkiM W M U
exam:
□Ctn
□Missed items,
tmsiitefs 
•k «Jilhctd lliirtfting StraugiFt
If msponse to ghidSdWt Ml «a*® "Vcs,"
Wlheo yon ware a  ch ild , d o  y o n  thiolc th a t  yon 
had  m ore pacoidems w ith  C dling to  pay  c lose  
a tten tio n  to  d e ta il o r  m ak in g  c a re le ss  
m la taltei th a n  m oat ch ild ren  y o u r age?
(iMnilB eornmmts/tijBimples/
Sijmpiaoi pæse.m m Sjjrrvkwri: irt dicfd'.hocti?
SS IV/f Tf Q t’a^ rrUi» O JWH ^ lohl MtikA frt. All light ifw.Ved h, thr US A. KW. i«x W&, X*nh Stada-atiAk, NV Ihiaahvmmxo HC.NuJg «TO %nd,w R,4 Atc.TcMaw.aN N2MAM& Thv . I 416^ 2 TMa di lülï
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SAMPLES OF THE CONNERS’ ADULT ADHD RATING SCALES (CAARS)
SELF-REPORT: LONG VERSION
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
124
CAARS-Self-Report: Long Version (CAARS-SiL)
by C. K. Conrwrs, Ph,D., D. Erhardt, & E. P. Sparrow, M,A.
Name:. . . . Gexiden M F
Birthdaite: / / Age: Today’s Date: ( /
(finlstjk':'
SI»*li t>iy >Va! Xlwih Day Vey
IlKtmctiwi LiKKil Mow att ïictas ciVKcniiii^  kctiaviœi e>i pmbkaii: sonhcliniiis siperiüiic&ü bf aiCallx. RciiJ uacli iliiin anil iltcWc haw
oiucis 01 \<aw each ileus ifcscciha yuu teranily. Indiw* yoar rMponjç f<jr each hcni (sy «rcliiij <lw iii»nil«r ih»t CiirisujKwiM W )*uic ilniicc,
Ifwc itK fnlhiwlciij ucalc: () ■* Nmi ai all, nesw: I »» Iwo n liiite. «ce in a tvlillc;
3 # tiaaii. olim; «ml 3 = Very tiiucli. very fr«|uc»il)'. \iw ai all. 
nt»Tf
Jtueulflllc,
«ntclns
wBik
PnNiypiurfev«fUii
Î.
6,
7,
S.
9,
II).
11.
1%
13.
14. 
I). 
16. 
1%
15. 
!9.
m
2t.
2Î.
23.
24.
25.
16. 
17. 
35, 
29. 
31). 
Jl,
32.
33.
I tite  10 be rSdbg iiaivo ihiogs.
[ lose thingis iwcunKiry W  isiO;» (iructlvitics 
(c.n.. lo-do lis», pcol'ils. bm*s. m KNOhS.
I éwi'i plan ahead,
[ hliiit w r  Ihiajs.
I am a ruâ^iuker or a (bmkWI.
I set dnwit on iiipejï.
! doai'i Hnbh ihiog» 1 alan.
I am eaaiiiy I'nasitaicd. 
i Wk loo flHich.
Ê am always on ihe go. as if tiriv'tn bjr a ni 
I'm dlsorgsaiiiMd.
I say ihings wiihooi ihiniftoj 
it’s liW  for <H610 sw>< in Jn f  jBSqe « ty  lonp 
I have troubla titling Msisie acrivjii 
i’m Mk sure of mgelf,
I ts  liortl fell' me tA j|A H i% W !kv& hl lliiitgh ai once.
I'm always m o v i j P ^  when I shrsiM k  siîll,
I forget lo remember things.
I Imvo a nleoH fmcAoi icinper.
I’m txwsl easily
I tew s my scsi wkm I am not supfhscd to.
I have iKitiblc wailing in liiw or laking hints with nih»-.
I slitl shrosy luitrunis.
I Imve trouble keo|tloe uty altcotion fbcnactl when wtnkrng. 
I w k  OUI fasi paced, eariitreg aesivliies.
I am id iscweltaitenges bccmisa I lack liiitb in my aWliric*
I feel MHlcss liisUte even if 1 am silting aillt.
Things I hear or see dislraei me from wha! I'm iMug.
1 am fisjëtful in tny daily aciiyiiies.
Many things set me off easily.
I dislike ijtitet, tntrospeetive «eiivltws.
I lose Wiiogs that I aeistl.
I Itave trot#te lishoimg to wfai tiiher people are sayiag.
1
iéi
ft$m$ co/ififsmd on ùack fisÿe..
j88Blaa||g S- , W/ii 0nÿ. NY if%SP21Ü2 tTM Vfkui&fikit RwAW %;:U f |<4iiMlS :f4t.^
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CAARS-Observer: Screening Version (CAARS“0:SV)
by C. KL Conners, Ph.D., D, Erharctt, PhD., & E. P. Sparrow, M.A.
VotirNamei
Gender: M F Gender: M F
(CiOeCnd
Ibdaÿ’eDele I am tfciis person’s; O  spouse O  paient O  sibling O  oihen
IwimMStMi Ut'W) kWoa* iirao^ MIr w i*«»aii*w r»*|«»iiy««bliwdkmWWfOiMOKMnOy, Mmieïeéf^ p^iwKieKliliembyanlMgihaiMiiilKftlaiemBpemblàpiw'eWké. bie#
I -  Jut a link, nnwin Swliik; jsrftetor ntitSh, «tefî V«y «luh, itiy Cmÿttailjf.
N«i u«il, rntiftiMh, VüïWttHi
«H» ««yüninaurTne pwsDW ù sim  desa îbed ...
loser things nscessaiy for tasks or activities 
esg.. tb«do lins, peneib, bocfe, or lOôls).
Is always on the go a* if dtiveo by a motor.
has a shorn fdsc/hot'tetnoer
iwwstamnims
has tTtsibi» Keeping atteetîtmfoçaséd w W  woAing or «  lelsu 
appm sr& W W %  slttiog Wll.
w laœetMia daily adivities
is #imderanhiever.
cw‘i get ##igs done.antes there's an eWutedeedlioo.
yingeinseaftcnacM to dM
doe*’(hkaeeedmk##3tWd(p*kËswh«ne(WMthWéigmMkmmW
, sometimes oveifocusbs oa é e t ^ ,  sà ojÉér tiines a^ipOars d b tiaded  t ÿ .
evetyihtng going on atmiiâ# bWhen
cotofdciod
intettunts. others they are worMon or
disteacted when iliinas ®« going on araawl him/ber.
* An w*, m iw« itw. imi
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CAARS-Observer: Long Version (CAARS-0:L)
by C. K. Conners, Ph.D., D. Erhardt, Ph.D., & E. P. Sparrow, M.A.
Name: Yiiiir Naitie:
G ender; M  F  A ge;..........
iCVrVyOnsi
G ender: M  F  _______
j (CketOA.)
Ibdav’sDatc; . !......  ( am llik jierson’s: O sjKiu.se 0  parent Q  srhSinc O  oilier:
M<Nh Vwr
iMimKlmw; WW pi4NM« MumamwcxÿwifiKWb) iiWüt RWi&kli iioxcWaUy mix&cf jxiw kx^wa«iy«Khiic^dkuchbé»ai»pmy*wfH jwm%pwn< %« F#6h iifm)? (»* mml*rih]icom«qpoMl( loyoï^ chcêw. Uwlher0lk*%lMfw#e; O-^XKaiall.ntYM;
I « Ju«iHuk.fflMtU*whtk:2-PiKiymiKh.oficfl:ïKH*J = %cymtt;h.«r>'fPS(iW!iib. |------------ jJt.atoHk, .'...
^  kjlM^ «nrrina CwHymiKh. >Vr>iniirh,
nr>rr w»#, «0«1Th& p erso n  b eing  üescfib ed ...
i .  loses citing ficcesiai; for !3skscTMWitl(» 
(e.^ .,io.<toUiLi. peiwiis, bools, «  leoJsi
0 1 a 3
a s e
6. down m  self. 
S. it KW^W AUMMKd
if dnvcGi b
12, tV ft ll)»DJ!X wichaail Uimbi»
14, «de n m w  or boiswrow duni«£ laisitit KuvUits.
16, Mt ft jatd Etwc kecmag ciacs: of sovesfti tiuocs ftt onto
18. fimm *0 eemeiidicf Amgs.
20. IS bored easily.
22, tiae troidili; wadinE in lift* or taking ttiraS viOi OlbeiS 
24. hftft imidiSo keeping atteajcrn foeiised wlwn i»odô% or «  kisure. 
26. avoids new dwIlenEes bKftose of bek of f#b  io bWkrftWKli*.
26, IS dtstrftcscd tw sU ts or ttwndft irylag loeoncenirabL
30. IS set off e»ily by many thin SlsTS*
32. loses ibsMui oftdiftd fw work or tasks.
/terns con tinuée/ on  à a ck  page..
im.SMI'iaiU3>i»»tlK,ftsri|tttwmelslk>UftA,lll9Mijnirit>U,4.NRtlT«»n»iLXSt<lsl.«eiMtlS.Mm. 
fi.taiaftj.»«»¥*i«urtaïAia«.rta*»ON
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